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1. Summary
Since the pioneering work of the Spanish neuroscientist Santiago Ramón y Cajal in the
beginning of the last century, it is widely accepted that the devastating consequences of spinal
cord injury are due to the failure of lesioned CNS axons to regenerate. In the past 20 years,
considerable progress has been made in understanding the cellular and molecular mechanisms
that contribute to the lack of successful regeneration of lesioned CNS axons. Based on these
findings, a range of promising intervention strategies has been developed and tested under
experimental conditions. Some of these strategies have even reached the stage of clinical
trials.
To date, however, relatively little is known about endogenous tissue repair processes which
occur during the first weeks after spinal cord injury. Some degree of abortive axonal
sprouting has commonly been detected in the lesioned spinal cord. In recent years, examples
of spontaneous axonal regeneration associated with highly organised glial cell invasion into
the lesion site have been reported after experimental and human spinal cord injury. These
observations led to the notion that the processes of cellular re-organisation and axonal
sprouting after spinal cord injury are much more organised and extensive than had previously
been appreciated. A better understanding of these re-organisational events could lead to the
identification of novel targets for intervention strategies.
The aim of the present study was to investigate novel aspects of the cellular and molecular
interactions that take place during attempted endogenous tissue repair following experimental
spinal cord injury in the rat.
The first part of the investigation demonstrates, for the first time, the expression of the cell
adhesion molecules L1 and N-CAM during extensive cellular invasion into the lesion site
following dorsal hemisection of the rat spinal cord. This thesis will show that the invasion of
the lesion site by non-neuronal cells and the distinct directionality, displayed by many of the
cellular and axonal components within the lesion site are associated with a strong and long-
lasting expression of the cell adhesion molecules L1 and N-CAM. The non-neuronal cells
within the lesion site rapidly formed a framework with an overall longitudinal orientation
which subsequently became associated with in-growing nerve fibres. Using double
immunofluorescence, it was possible to identify Schwann cells and leptomeningeal cells
contributing to the pattern of cell adhesion molecule expression within the lesion. Many of the
regenerating nerve fibres entered the lesion site from both the rostral and caudal intact spinal
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cord. At the lesion interface, these axons passed through regions of intimately intermingled
and longitudinally orientated processes of reactive astrocytes and Schwann
cells/leptomeningeal cells.
In the second part of the investigation, immunohistochemistry for the detection of epithelial
membrane antigen (EMA) was performed in an attempt to identify perineurial cells in the
lesion site after compression injury of the rat spinal cord. Similar to Schwann cells,
perineurial cells are components of peripheral nerves and known to play an important role
during peripheral nerve regeneration. This behaviour led to the notion that perineurial cells or
perineurial-like cells of the spinal nerve roots might also participate in the re-organisational
events taking place after spinal cord injury. In the present investigation EMA-
immunoreactivity was detectable in unlesioned and lesioned spinal nerve roots but not in the
unlesioned spinal cord. In the lesioned spinal cord, EMA-positive cells were detectable as
early as 14 days p.o. Surprisingly, neither the distribution of the stained profiles in the nerve
roots, nor the morphology of the immunoreactive cells in the roots and in the lesion site
resembled that of perineurial cells. Therefore, additional investigations, including double
immunofluorescence with a range of antibodies, were performed. These studies led to the
conclusion that, under the present experiment conditions, the anti-EMA antibody was
identifying myelin-forming Schwann cells rather than perineurial cells.
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2. Introduction
2.1. Traumatic spinal cord injury
In Germany, approximately 50.000 people suffer from the devastating consequences of
traumatic spinal cord injury (SCI), and every year about 1.600 new cases are reported (Exner,
G., personal communication). The motor, sensory and autonomic disturbances presented by
patients, are largely due to the permanent disruption of central long and short distance nerve
fibre pathways but also result from damage to spinal neurons at and around the site of injury
(for recent review see Sekhon and Fehlings, 2001). Although new rehabilitation concepts,
including treadmill or ”Laufband” treatment, as well as functional electric stimulation have
improved the situation for many patients (Dietz, 2001; Hesse, 2001; Wirz et al., 2001), the
neurological deficits and secondary problems, such as decubitous ulcers and autonomic
dysreflexia that are caused by severe injuries, usually persist for life.
In the CNS, sprouting of lesioned axons occurs during the first few days after injury.
However, these axons fail to extend over distances greater than 1 mm and sprouting is, in fact,
soon aborted. The first detailed description of the failure of lesioned CNS axons to re-grow
was provided by the Spanish neuroscientist Santiago Ramón y Cajal (Ramón y Cajal, 1928).
He concluded:
”It cannot be denied, therefore, that the central axons have the property of producing
new fibres. In adult centres the nerve paths are somewhat fixed, ended, immutable.
Everything may die, nothing may be regenerated. It is for the science of the future to
change, if possible, this harsh decree. Inspired with high ideals, it must work to impede
or moderate the gradual decay of the neurons, to overcome the almost invincible rigidity
of their connections, and to re-establish normal nerve paths.”
It is now widely accepted that the failure of axonal regeneration in the CNS of adult mammals
is due to a combination of reasons, including the influence of an hostile glial environment
surrounding damaged axons and the limited regenerative response of axotomised intrinsic
CNS neurons. Since the pioneering work of Ramón y Cajal, many of the cellular and
molecular mechanisms which contribute to the prevention of functional CNS axonal
regeneration, have been identified (for reviews see: Schwab and Bartholdi, 1996; Fawcett and
Asher, 1999). Almost all of these advances have been made during the last 20 years.
Furthermore, a number of promising intervention strategies has been developed and tested in
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experimental animals (for recent reviews see: Fawcett, 1998; Schwab, 2002). Some of these
strategies have even entered clinical trials in recent years (for recent review see Wickelgren,
2002). However, despite the hope generated by these trials, there is currently still no clinical
treatment available that can successfully repair a human spinal cord following injury.
In contrast to the non-regenerative properties of the lesioned adult mammalian CNS,
successful axonal regeneration usually occurs after peripheral nerve injury (e.g. Ramón y
Cajal, 1928; Bunge, 1993). Severed axons form sprouts which grow through a favourable
environment of mitotic and de-differentiated Schwann cells and can re-establish synaptic
connections with their original targets.
2.2. Successful axonal regeneration in the peripheral nervous system (PNS)
The lesioned PNS has been used as an experimental model to study the cellular and molecular
events which lead to successful axonal regeneration (Ramón y Cajal, 1928; Thomas and
Jones, 1967; Raivich and Kreutzberg, 1993). After peripheral nerve injury, efficient axonal
sprouting normally leads to the re-innervation of denervated targets, resulting in functional
restitution. The ability of the mammalian PNS to regenerate is primarily due to the immense
plasticity of a specialised population of PNS glia, the Schwann cell. However, activated
macrophages and perineurial fibroblasts are also known to play a role (Thomas and Jones,
1967; Bunge, 1993). Peripheral nerve lesions are followed by a highly stereotyped sequence
of events. The degeneration of axons and their myelin sheaths triggers a massive invasion of
macrophages into the nerves. Phagocytosis of myelin debris leads to the synthesis and
secretion of numerous cytokines, enzymes and growth factors by activated macrophages
(Perry et al., 1987). The release of interleukin-1 (IL-1) has been reported to induce mitosis
and the de-differentiation of Schwann cells with a concomitant modification of protein
synthesis (Heumann et al., 1987; Lisak et al., 1994). The de-differentiated Schwann cells
down-regulate myelin-associated molecules and up-regulate the expression of a number of
neurotrophic, growth-promoting molecules, such as nerve growth factor (NGF) and brain-
derived nerve growth factor (BDNF) (Meyer et al., 1992; Raivich and Kreutzberg, 1993).
These molecules not only support axonal regeneration but also enhance the survival and
sprouting of damaged nerve cells. A prominent increase in the re-expression of the low
affinity nerve-growth-factor-receptor (NGFr) by Schwann cells distal to the lesion has been
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suggested to concentrate the secreted neurotrophins on the Schwann cell surface (Taniuchi et
al., 1988).
Schwann cells also produce a range of growth-promoting extracellular matrix (ECM)
molecules, such as laminin and fibronectin (Bunge, 1993; Martini, 1994) and a number of cell
adhesion molecules, including L1 and neural cell adhesion molecule (N-CAM) (Seilheimer
and Schachner, 1987; Bixby et al., 1988). Cell adhesion molecules in general (and L1 and N-
CAM in particular) play an important role in the initial contacts between Schwann cells and
axons, in axon fasciculation, growth-cone motility and myelination of large diameter axons
during neural development and PNS regeneration (Edelman, 1983; Rutishauser and Jessell,
1988; Sonderegger and Rathjen, 1992; Carbonetto and David, 1993).
After peripheral nerve injury, the de-differentiated Schwann cells form columns of orientated
cells and processes (referred to as bands of Büngner), through which regenerating axons are
guided (Griffin and Hoffmann, 1993; Gilmore and Sims, 1995). In addition to Schwann cells,
perineurial cells have also been reported to play a major role in peripheral nerve regeneration
(Thomas and Jones, 1967; Ohara et al., 1986; Weis et al., 1994) by providing a guiding
structure for re-growing Schwann cells and axons (see below).
In the axotomised motoneural cell bodies, a neuronal program for axonal re-growth is
initiated. Neuronal somata show a dramatic change in protein biosynthesis, including the re-
expression of certain molecules normally found during development (Bähr and Bonhoeffer,
1994). For example, the up-regulation of the transcription factor or immediate early gene c-
jun has been correlated with increased expression of the growth-associated glycoprotein 43
(GAP-43) (Woolf et al., 1990; Herdegen et al., 1997). This molecule is widely acknowledged
to play a major role in sprouting and plasticity of the nervous system (Nacimiento et al., 1993;
Kapfhammer and Schwab, 1994). Another recently detected component of the PNS
regeneration program is the up-regulation of cyclic-adenosine-monophosphate (cAMP) in
axotomised peripheral neurons (for review see Snider et al., 2002). It has been reported that
high levels of cAMP may improve the intrinsic growth capacity of lesioned peripheral
neurons by enhancing growth-cone advance and/or by regulating the response of regenerating
neurons to environmental inhibitory cues. The exact processes, however, which are
influenced by this cyclic nucleotide, have yet to be fully characterised.
Finally, a new basement membrane forms around the outer surface of the Schwann cells
which ensheath several regenerating axons. Large diameter axons are ensheathed in a 1:1
relationship and subsequently become myelinated (Bunge et al., 1990). The myelinating
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Schwann cells down-regulate NGFr and the cell adhesion molecules L1 and N-CAM, while
non-myelinating Schwann cells remain weakly L1-, N-CAM- and NGFr-positive (Mirsky et
al., 1986; Jessen et al., 1987; Taniuchi et al., 1988).
In summary, in order to regenerate, the lesioned PNS is able to re-initiate important
developmental events, including the supply of tropic and trophic support and the prolonged
re-expression of regeneration-associated molecules. As explained in more detail below, these
events are absent or only transiently induced in the lesioned CNS.
2.2.1. The perineurium and the role of perineurial cells in peripheral nerve regeneration
The pioneering studies describing peripheral nerve connective tissue, date back to the
nineteenth century (Henle, 1841; Ranvier, 1871/72; Key and Retzius, 1876; Retzius, 1898).
The terminology of an endo-, peri-, and epineurium was formulated by Key and Retzius in
1873 and is still in use today (Key and Retzius, 1873). The endoneurium surrounds each
nerve fibre, while the perineurium isolates individual nerve fascicles from the epineurial
connective tissue. The epineurium forms the outer surface of a peripheral nerve.
The perineurium constitutes the basis for the regulation of endoneurial fluid homeostasis and
therefore is comparable to the blood brain barrier of the CNS. It protects the Schwann cell
axon units and the endoneurial connective tissue from ionic alterations, antigens, toxins and
infectious agents (Klemm, 1970).
The perineurial sheath consist of one to several concentric layers of thin, flattened perineurial
cells which alternate with various numbers of collagen fibrils (Akert et al., 1976). Relatively
thick basement membranes surround the cells on both the epineurial and the endoneurial side
(Thomas, 1963; Gamble and Eames, 1964). These basement membranes, which participate in
the barrier function, are mainly made up of collagen type IV associated with a number of
glycoproteins, including laminin and fibronectin (Peltonen et al., 1987; Jaakkola et al., 1989).
Tight junctions firmly adhere the concentric layers and slender processes of these cells (Akert
et al., 1976). The continuity of the perineurium is only interrupted where blood vessels exit
the endoneurium and near the termination of nerve fibres (Burkel, 1967). Distally, as the
nerve begins to branch, the perineurial sheaths thin out, and near the nerve ending only a
single layer of perineurial cells is apparent (Burkel, 1967).
A peripheral nerve begins where nerve roots attach to the central nervous system (see
Schematic Figure 1). The nerve roots traverse the subarachnoid space between the CNS and
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the subarachnoid angle and pierce the dura mater. In this transition zone between the PNS and
CNS, the perineurium blends into the pia-arachnoid. It has been reported that the nerve root
sheaths possess a unique histological organisation and do not correspond exactly to any other
lining structures, such as the perineurium or the pia-arachnoid (Benke and Röhlich, 1963;
Haller and Low, 1970; Radek et al., 1986).
Schematic Figure 1
Schematic drawing which shows the relationship of the peripheral nerve sheaths to the meningeal covering in
the region of a dorsal nerve root (modified from Benke and Röhlich, 1963). The epineurium (EP) is in direct
continuity with the dura mater (DM), and the dorsal root ganglion (DRG) is surrounded by a normal
perineurium (PN). At the subarachnoid angle (SA) the perineurium appears to continue onto the nerve root (NR)
by forming the inner layers of the root sheath (RS), which encloses the nerve root. As the nerve root passes
through the subarachnoid space, the arachnoid (A) forms the superficial layers of the root sheath. At the junction
with the spinal cord (SC), the outer layers of the sheaths are continuous with the pia mater (PM).
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In the subarachnoid space, perineurial-like cells are detectable on the inner surface of the
multilayered root sheath, whereas arachnoid-like cells appear on the outer surface (Benke and
Röhlich, 1963; Haller and Low, 1970). Characteristics shared by the perineurium and the
inner part of the root sheath, are the layers of flattened cells and the close cellular contacts
between these layers. Boundary membranes, regularly detectable on perineurial cells, appear
only irregularly on or are absent from the cells of the nerve roots except for a continuous
membrane that separates the basal cells of the root sheath from the endoneurium (Haller and
Low, 1970). A regular perineurial sheath forms shortly proximal to the dorsal root ganglion
(Benke and Röhlich, 1963).
The origin of the perineurium was, for many years, a controversial issue. It is now widely
accepted that the perineurium originates from the differentiation of fibroblasts, and thus
develops from the local connective mesenchyme. This has been shown by investigations,
which used the quail-chick chimera method or a retroviral marker (Haninec, 1988; Bunge et
al., 1989).
As mentioned earlier, perineurial cells are reportedly important for successful peripheral
nerve regeneration. According to several reports, perineurial cells are the first cells to re-
connect the proximal and distal stump after experimental peripheral nerve lesion, and thereby
form a guiding structure for re-growing Schwann cells and axons (Thomas and Jones, 1967;
Scaravilli, 1984; Schröder et al., 1993; Weis et al., 1994). Following nerve injury, perineurial
cells lose their characteristic phenotype and adopt a fibroblast-like appearance (Thomas and
Bhagat, 1978; Ohara et al., 1986). No basal lamina or intercellular junctions are detectable in
these cells. It has been proposed that in-growing Schwann cell-axon bundles might be
responsible for their re-transformation into perineurial cells (Thomas and Bhagat, 1978;
Scaravilli, 1984; Schröder et al., 1993). However, the exact mechanisms leading to this
important step in perineurial cell differentiation remain unknown. With the re-acquisition of
the perineurial phenotype, new intercellular junctions are established between adjacent cells
and the typical basal lamina reforms (Morris et al., 1972; Salonen et al., 1987).
In the second part of the present investigation, we wished to assess the hypothesis that, after
spinal cord compression injury, perineurial cells or perineurial-like cells of the root sheaths
rapidly migrate into the lesion site and establish an orientated cellular framework which might
act as guiding structure for subsequently in-growing Schwann cells. To date, there is only a
single report of perineurial cell appearance in a spinal cord lesion. Matthews and colleagues
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identified perineurial cells surrounding Schwann cells in the lesion site of rat spinal cords by
electron microscopy (Matthews et al., 1979).
A popular method to immunohistochemically identify perineurial cells is by using an
antibody against epithelial membrane antigen (EMA). The presence of EMA on perineurial
cells was first detected in the mid 1980’s (Pinkus and Kurtin, 1985). EMA is a large
glycoprotein, expressed by a range of normal and neoplastic epithelial tissues, but also by
various tissues of mesenchymal origin (Sloane and Ormerod, 1981; Perentes et al., 1987). The
anti-EMA antibody, raised against a group of human milk fat globule membranes, plays an
important role in the diagnosis and differential diagnosis of cancers of epithelial organs
(Sloane and Ormerod, 1981; Pinkus and Kurtin, 1985; Perentes et al., 1987).
2.3. Cellular and molecular mechanisms involved in the failure of CNS axon
regeneration
2.3.1. Oligodendrocytes and central myelin
The concept of inhibitory properties of central myelin was first suggested by M. Berry in
1982 (Berry, 1982). In 1988, Caroni and Schwab identified an extremely potent myelin-
associated inhibitor, termed NI-35/250, which is constitutively present on the cell surface of
adult myelinating oligodendrocytes (Caroni and Schwab, 1988b). This large, membrane-
bound glycoprotein has been demonstrated to induce rapid, contact-mediated growth-cone
collapse by a calcium dependent mechanism (Bandtlow et al., 1993). Recently, the cDNA of
human NI-35/250 has been cloned, and it has been shown that the corresponding gene, called
”Nogo”, gives rise to three alternative isoforms (Nogo-A, B and C) which are members of the
reticulon family (Chen et al., 2000; GrandPre et al., 2000; Prinjha et al., 2000). The largest
splice variant, Nogo-A, which appears to be NI-250, is highly expressed by oligodendrocytes
and has the strongest inhibitory activity in culture, while the functions of Nogo-B (probably
NI-35) and Nogo-C have yet to be fully characterised (Bandtlow and Schwab, 2000; Chen et
al., 2000; GrandPre et al., 2000; Prinjha et al., 2000). More recently a functional cell surface
receptor, named NGr, that mediates the inhibitory effects of the extracellular domain of
Nogo-A (Nogo-66) has been identified by Fournier and colleagues (Fournier et al., 2001).
The identification of Nogo and NGr are important advances in understanding axon inhibition
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by CNS myelin and may provide a new molecular basis to study regeneration and probably
also to design novel therapeutic strategies.
Another growth-inhibitory protein of central myelin is the myelin-associated glycoprotein
(MAG) (McKerracher et al., 1994; Tang et al., 1997). In the lesioned PNS, where this protein
is also expressed, myelin debris is quickly cleared during the massive invasion by
phagocytically active macrophages. In the lesioned CNS, macrophage recruitment into the
lesion site is less pronounced and the removal of myelin debris is much slower, resulting in a
prolonged exposure of nerve sprouts to these inhibitory molecules (Perry et al., 1993; Schnell
and Schwab, 1993; Perry et al., 1987). It has recently been reported that MAG also exerts its
growth-inhibitory properties by acting through the Nogo-receptor NGr (Liu et al., 2002).
Oligodendrocytes furthermore produce the ECM-molecule tenascin-R, which is up-regulated
after injury and has been shown to restrict axonal growth in tissue culture experiments
(Fawcett and Asher, 1999). Oligodendrocyte precursor cells, of which a large number have
been identified in the non-lesioned CNS, are also recruited to areas of SCI (Keirsted et al.,
1998). These cells constitutively express the proteoglycans NG2, DSD-I/phosphocan and
neurocan, which have all been shown to inhibit axonal growth in tissue culture (Dou and
Levine, 1994; Fawcett and Asher, 1999; Garwood et al., 1999).
2.3.2. Astrocytes
The glial scar which forms after CNS injury predominantly consists of reactive astrocytes.
Traumatic injury induces astrocytic proliferation, and the hypertrophic processes of these
reactive cells form a tightly linked mesh by cell-cell interactions of gap and tight junctions.
This dense network of overlapping astrocytic processes presents a region of very limited
extracellular space and has long been regarded to form a mechanical barrier to axon
regeneration (Reier et al., 1983; Hatten et al., 1991). This concept has more recently been
challenged, and it now seems that changes in the molecular properties of reactive astrocytes
might play a more important role in the early inhibition of axonal regeneration. In vitro
studies have demonstrated that reactive astrocytes express a number of neurite growth-
promoting and inhibitory molecules. For example, the growth-promoting ECM-molecules
laminin and fibronectin are expressed by these cells (Hirsch and Bahr, 1999), but their
potential beneficial effects are apparently over-ridden by the expression of growth-inhibitory
molecules such as tenascin-C and chondroitin sulphate proteoglycan (CSPG) (McKeon et al.,
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1991; Canning et al., 1996; Davies et al., 1997). Many of these proteoglycans are
developmentally regulated and play an important role in the determination of the pattern of
neurite outgrowth during the formation of the CNS by acting as repulsive molecules to axons.
Their re-expression in the injured mature CNS appears to be a major factor in the prevention
of axon regeneration (Fitch and Silver, 1997; Fawcett and Asher, 1999).
2.3.3. Neurons: intrinsic state
As mentioned above, in addition to the unfavourable glial environment, intrinsic neuronal
properties also play a role in the regenerative response to injury (Fawcett, 1992; Tetzlaff et
al., 1994). If axotomised central neurons are to regenerate, they must first survive the insult.
The cell body response of axotomised CNS neurons (ranging from cell death to mild atrophy)
strongly depends on the proximity of the lesion to the perikaryon (Richardson et al., 1984;
Sofroniew and Isacson, 1988). Axotomy, taking place close to the cell body, results in a
higher likelihood of cell death, but also in the induction of a stronger regenerative response.
Lesions far away from the cell body result in a lower likelihood of cell death but in a weaker
regenerative response. This phenomenon has been termed ”the near-far effect” and might play
a major role in the failure of functional regeneration following SCI, since it has a profound
effect on many important long-distance ascending and descending fibre tracts.
As described earlier, the up-regulation of several regeneration-associated genes and proteins
in the neuronal cell bodies is a prerequisite for successful axonal regeneration in the PNS.
Although axotomy of CNS neurons also induces profound changes in the expression of some
of these genes and proteins, CNS axons only possess a very limited capacity to regenerate. C-
jun and GAP-43, as well as the cytoskeletal components, actin and T-α1-tubulin, are only
transiently up-regulated during the first two weeks after axotomy (Herdegen et al., 1991;
Tetzlaff et al., 1991; Jenkins et al., 1993; Broude et al., 1997; Schmitt et al., 1999). The
reason for this temporally limited up-regulation might lie in the molecular influence of the
inhibitory glial environment and/or also in a generally insufficient level of trophic support in
the lesioned adult CNS. It is highly likely that the transient cell body response contributes to
the eventual retraction of axonal sprouts (Schwab and Bartholdi, 1996).
It has furthermore been reported that, in contrast to peripheral nerve injury, SCI does not
cause a substantial increase of endogenous cAMP in the axotomised neurons (Filbin, 1999).
This difference in the expression of cAMP after axotomy between peripheral and central
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neurons may probably be an additional reason for the lack of adequate axonal regeneration in
the CNS. More recently it has been shown that micro-injection of a membrane-permeable
analogue of cAMP (db-cAMP) into rat dorsal root ganglia, markedly increased the
regeneration of injured dorsal column axons (Neumann et al., 2002; Qiu et al., 2002).
A number of experimental intervention strategies, designed to promote useful axonal
regeneration have been developed in recent years. These include enhancing the regenerative
drive of axotomised CNS neurons, interfering with the local growth-inhibitory cues and
transplanting a growth-promoting environment into the lesion site.
2.4. Therapeutic strategies to enhance anatomical plasticity and recovery of function
after spinal cord injury
Two strategies that have reached clinical trials, are to reduce secondary tissue damage and to
improve the function of surviving axons.
The inflammatory response, taking place at the lesion site after SCI, is known to contribute to
secondary tissue damage, which develops after the initial lesion (Blight, 1992; Dusart and
Schwab, 1994). These detrimental effects are believed to be due to the production of free
radicals, arachidonic acid derivates, cytotoxic cytokines and tissue swelling (Hall and
Braughler, 1989; Dusart and Schwab, 1994). Pharmacological intervention during the first
hours after SCI has been reported to counteract some of these events (Hall and Braughler,
1982; Dusart and Schwab, 1994). High dose methylprednisolone treatment (30mg/kg body
weight) during the first 8 hours of injury is now widely used in acute treatment after human
SCI (Bracken et al., 1997). It is believed that early high dose methylprednisolone application
functions by scavenging free radicals rather than by an anti-inflammatory effect (Hall and
Braughler, 1982). Experimental data have provided convincing evidence that early
methylprednisolone doses reduce tissue destruction (Oudega et al., 1999), and numerous
clinical trials have shown that the application of methylprednisolone within the first eight
hours after a spinal cord trauma results in a modest but significantly improved clinical
outcome for spinal cord injured patients (Bracken, 2001; Bracken, 2002).
Application of the potassium channel blocker famripidine (chemically, 4-aminopyridine
(4-AP)), has been reported to maintain axonal function of nerve fibres that survived the
original trauma. After SCI, myelin sheaths of spared fibres often sustain damage revealing
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potassium channels in paranodal regions. The activation of these channels results in an
impaired conduction of action potentials (for review see Nashmi and Fehlings, 2001). 4-AP
directly blocks potassium channels on the axonal surface and thereby prevents potassium
efflux, supporting the conduction of action potentials across partially demyelinated surviving
axons (Haghighi et al., 1995). The first results from preclinical trials provided evidence that
famripidine only modestly improved motor and sensory functions in human patients, but also
that the drug significantly reduced spasticity and involuntary jerking of the limbs and
improved bladder and sexual function (Potter et al., 1998; Segal et al., 1999). Large-scale
clinical trials which began this summer, will hopefully provide further information to resolve
the question if the application of famripidine is a suitable pharmacological treatment for
spinal cord injury patients.
Other intervention strategies have been developed to reconnect severed central nerve fibres to
their original targets. Many of these strategies have focused on the transplantation of growth-
supporting substrates into the lesion site. To be effective, the transplants must attract axons
from different sources, convey them into and across the lesion site, allow them to re-enter the
host tissue and guide them to their proper targets. Peripheral nerve segments, purified glia
cells (Schwann cells and/or olfactory nerve ensheathing cells), genetically modified
fibroblasts, embryonic CNS tissues, stem cells and macrophages have all been transplanted
into spinal cord lesions in experimental animals with varying degrees of success (e.g. Aguayo
et al., 1983; Iwashita et al., 1994; Reier et al., 1994; Cheng et al., 1996; Lazarov-Spiegler et
al., 1996; Martin et al., 1996; Tuszynski et al., 1996; Ramon-Cueto et al., 1998). One of the
major stimuli that continue to drive this line of investigation is the fact that only a small
percentage (5-10%) of severed nerve fibres need to achieve successful regeneration to restore
a useful degree of motor and sensory function (Young, 1993). Therefore, only a partially
successful strategy could, in theory, deliver substantial benefits to the lesioned subject.
The development of a monoclonal antibody (IN-1), which is capable of neutralising Nogo-A,
was an important step in blocking the inhibitory activities of the CNS glial environment.
Application of IN-1 prevents growth-cone collapse in vitro and enhances anatomical
plasticity and regeneration of a variety of lesioned fibre tracts in vivo (Caroni and Schwab,
1988a; Schnell and Schwab, 1993). Significant axonal regeneration and sprouting, induced by
the administration of this antibody, with or without the accompaniment of infusions of
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different neurotrophins, has resulted in a remarkable degree of functional recovery in
experimental animals (Bregman et al., 1995; Merkler et al., 2001).
More recently, active and passive immunisation of CNS-injured rats or mice with myelin-
associated peptides such as Nogo-A and myelin basic protein (MBP), has resulted in
significant recovery after spinal cord contusion injury (Hauben et al., 2001a; Hauben et al.,
2001b). The beneficial effect of this kind of vaccination has been reported to lie in the
induction of a T-cell-mediated protective autoimmune response (Schwartz and Cohen, 2000).
However, it must be considered that this intervention concept also includes the likelihood of
inducing an autoimmune disease or interfering with essential functions of central myelin or
other proteins.
Regeneration of SCI is a very complex event. A single intervention strategy only provides
regenerative support to certain aspects of this complexity. Therefore, it is highly likely that a
combination of different strategies would improve the structural and functional restoration
after spinal cord trauma. In experimental animals, combinations of different therapies have
been shown to improve the regenerative response (e.g. Schnell et al., 1994; Bregman et al.,
1997a; Bregman et al., 1997b; Ye and Houle, 1997; Bregman et al., 1998; Ramon-Cueto et
al., 1998; Oudega and Hagg, 1999; Bamber et al., 2001; McDonald and Sadowsky, 2002).
However, most intervention strategies are still far from being applicable to the clinical
situation. The conditions in the experimental situation are controlled, optimised and
standardised for small laboratory animals. Human SCI, in contrast,  is highly variable in terms
of type, severity and segmental level. Given this fact, it will be difficult to choose an
appropriate strategy for each individual situation. Furthermore, most of the promising
experimental strategies require extensive surgical intervention. The transfer of these
approaches to the clinical situation involves the risk of causing further damage to spared
populations of nerve fibres, which are known to maintain, at least, some residual function
after SCI.
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2.5. Endogenous tissue repair
In recent years, examples of spontaneous axonal regeneration have been observed after
experimental and human SCI (Guth et al., 1994; Wang et al., 1996; Beattie et al., 1997; Brook
et al., 1998). In autopsy material from traumatically injured human spinal cords, Wang and
colleagues detected regenerated axons associated with myelin-forming Schwann cells running
parallel to the longitudinal axis of the cord (Wang et al., 1996). This phenomenon could also
be observed in experimentally injured rat spinal cords (Guth et al., 1994; Beattie et al., 1997;
Brook et al., 1998). It has been shown that Schwann cell invasion can lead to the formation of
longitudinally orientated arrays of these cells, which might partly replace the loss of the
highly orientated glial cytoarchitecture normally present in the spinal cord white matter tracts
(Suzuki and Raisman, 1992). A significant number of regenerated axons within the lesion site
shows that, under some conditions, endogenous tissue repair is capable of providing
appropriate stimuli for directional axonal re-growth.
Another cell type which might be involved in endogenous repair after SCI is the ependymal
cell. Proliferating ependymal cells express nestin and form cellular trabeculae within the
lesion, and therefore it is possible that these cells might guide central nerve fibres into the
lesion site (Guth et al., 1994; Liu et al., 2002).
These observations have led to the current opinion that the processes of cellular re-
organisation and axonal sprouting that occur during attempted endogenous tissue repair are
highly organised and more extensive than had previously been appreciated. However, to date,
the mechanisms which regulate these endogenous tissue repair processes are only poorly
understood. A better understanding of the cellular and molecular interactions during
attempted endogenous tissue repair will probably lead to the identification of novel targets for
intervention strategies, such that manipulation or enhancement of endogenous tissue repair
might improve the regenerative response of severed central nerve pathways.
The goal of the first part of present investigation was to identify the possible involvement of
the neural cell adhesion molecules L1 and N-CAM in the tissue re-organisation taking place
after experimental SCI. L1 and N-CAM have already been identified to be important in
axonal growth, guidance, and fasciculation during neural development and PNS regeneration
(Rutishauser and Jessell, 1988; Martini, 1994; Joosten and Bär, 1999), but their involvement
in attempted endogenous tissue repair was, prior to this study, unknown.
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2.6. The cell adhesion molecules L1 and N-CAM
The cell adhesion molecules L1 and N-CAM are expressed by both, Schwann cells and axons
during neuronal development and by non-myelinating Schwann cells in the mature PNS
(Martini and Schachner, 1986; Jessen et al., 1987; Rutishauser and Jessell, 1988; Martini,
1994). After peripheral nerve injury, they are re-expressed in de-differentiated Schwann cells
and axons (Daniloff et al., 1986; Martini and Schachner, 1986; Jessen et al., 1987; Tacke and
Martini, 1990; Martini, 1994). The two molecules play an important role in initial Schwann
cell-Schwann cell, Schwann cell-axon and axon-axon contacts (Martini and Schachner, 1986;
Martini, 1994). Their presence is fundamental to growth-cone mobility and neurite elongation
(Burden-Gulley et al., 1995; Kamiguchi and Lemmon, 1997). Furthermore, they mediate
interactions during Schwann cell ensheathment and myelination of axons (Edelman, 1983;
Martini, 1994).
2.6.1. L1
L1 is a transmembrane glycoprotein belonging to the
immunoglobulin-like superfamily of adhesion molecules. It
has a molecular weight of 190-230 kDa, and its
extracellular region contains five fibronectin type III
repeats and six immunoglobulin-like domains (Rathjen and
Schachner, 1984; Moos et al., 1988). Homophilic, assisted
homophilic and heterophilic binding of L1 molecules seem
to play an important role in neuronal elongation, axon
fasciculation and initiation of myelination (Kamiguchi and
Lemmon, 1997).
L1 mediates Schwann cell-Schwann cell adhesion which
might be partly involved in the adoption of linear spatial
arrays by these cells (Bands of Büngner) following
peripheral nerve injury (Seilheimer and Schachner, 1988).
L1 is also important for Schwann cell adhesion to axons,
and might therefore be responsible for the correct guidance
of outgrowing axons (Bixby et al., 1988; Seilheimer and
Schematic Figure 2
Molecular structure of the cell
adhesion molecule L1 (modified from
Rutishauser, 1989)
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Schachner, 1988). Transplantation of Schwann cells into the transected optic nerve has
demonstrated that L1 is important for supporting the regeneration of retinal ganglion cell
axons (Dezawa and Adachi-Usami, 2000). Furthermore, L1 is involved in axon interactions,
particularly in axon fasciculation, by supporting neurite extension along bundles of pre-
existing axons (Rathjen and Schachner, 1984; Martini and Schachner, 1986). L1 also seems to
promote growth-cone motility by interfering with the motive apparatus, and reportedly
increases the state of tubulin polymerisation in growth-cone membranes (Atashi et al., 1992).
Tissue culture experiments have shown that the application of L1 antibodies significantly
reduces neurite outgrowth, Schwann cell ensheathment and myelination of axons (Seilheimer
and Schachner, 1988; Seilheimer et al., 1989; Wood et al., 1990). Following peripheral nerve
injury, NGF increases the expression of L1 on axons and Schwann cells (Bock et al., 1985;
Friedlander et al., 1986; Seilheimer and Schachner, 1987). L1-L1 interaction on the surfaces
of these cells is markedly increased by functional association with N-CAM (assisted
homophilic binding) (Kadmon et al., 1990; Kadmon et al., 1990). Furthermore it has been
reported that heterophilic L1 binding mediates adhesion between unmyelinated sensory axons
and Schwann cells (Haney et al., 1999). Due to the absence of L1 on central glia cells
(Seilheimer and Schachner, 1988), interactions of L1-positive axons and L1-negative
astroglial cells are also mediated by heterophilic interactions (Grumet and Edelmann, 1988).
2.6.2. N-CAM
N-CAM is also a member of the
immunoglobulin-like superfamily of
adhesion molecules. Three isoforms of
120, 140, and 180 kDa are produced by
alternative splicing of one gene and
differ in the length of their carboxy
terminal (Owens et al., 1987; Barbas et
al., 1988). All three isoforms have the
same extracellularly located region,
containing five immunoglobulin-like
domains and two fibronectin III repeats
(Barthels et al., 1987; Cunningham et al., 1987). The different isoforms of N-CAM seem to
Schematic Figure 3
Molecular structure of the 3 isoforms of the cell adhesion
molecule N-CAM (modified from Daniloff et al., 1994)
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play different roles in morphogenesis of the nervous system (Frei et al., 1992). The lower
molecular weight forms have been reported to be important for growth-cones in their mobile,
searching phases (Trinkaus, 1985), while N-CAM 180 is believed to be involved in axonal and
synaptic stabilisation, due to its lower lateral mobility within the surface membrane (Pollerberg
et al., 1986).
Polysialylated acid (PSA), which is associated with N-CAM during development, reduces the
adhesive properties of the molecule (Cunningham et al., 1983; Hoffman and Edelman, 1983).
The coating of N-CAM by PSA during this phase might be important by preventing stable
adhesion between outgrowing axons, thus facilitating axonal branching (Joosten, 1994;
Daston et al., 1996). The conversion from the embryonic form of N-CAM (PSA-N-CAM) to
the more adhesive adult form assists in the stabilisation of contacts between Schwann cells
and Schwann cells, Schwann cells and axons, fasciculating axons and between some boutons
and their post-synaptic targets (Edelman, 1983; Rutishauser et al., 1988).
Furthermore, N-CAM 180 interacts with brain spectrin, a cytoskeleton-membrane linker
protein in growth-cones, and thereby might support growth-cone mobility and axonal
elongation (Pollerberg et al., 1986; Pollerberg et al., 1987). Application of N-CAM antibodies
in tissue culture has shown that N-CAM might be involved in Schwann cell mediated neurite
elongation, although to a lesser extent than L1 (Chang et al., 1987; Seilheimer and Schachner,
1988). The association of Schwann cells with axon bundles remained relatively unaffected by
the application of anti-N-CAM antibodies (Seilheimer et al., 1989). In the CNS, immature
astrocytes and oligodendrocytes predominantly express polysialylated and lower molecular
weight forms of N-CAM, whereas in the mature CNS these cells mainly express the non-
polysialylated N-CAM 180 (Keilhauer et al., 1985; Daniloff et al., 1994).
2.7. Hypotheses tested in the investigations
In the first series of investigations we tested the hypotheses that:
− the formation of a longitudinally orientated cellular matrix within the lesion site after SCI
is not a lesion model dependent phenomenon.
 
− L1, N-CAM and PSA-N-CAM are all highly expressed during the tissue re-organisation
that takes place after dorsal hemisection of the rat spinal cord.
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 In the second series of investigations we tested the hypotheses that:
 
 
− perineurial-like cells can be detected by the use of an anti-EMA antibody and that these
cells rapidly migrate into the lesion site after spinal cord compression injury.
 
− migrating perineurial-like cells adopt a longitudinal orientation within the lesion site.
 
− Schwann cells which subsequently migrate into the lesion associate with the perineurial-
like cells to form a growth-promoting glial matrix.
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3. Material and methods
3.1. Animals
A total of 68 male adult Wistar rats were used in the studies. All surgical procedures were
performed in collaboration with the Centre for Cellular and Molecular Neurobiology of the
University of Liège, Liège, Belgium (compression injury model) and the Departments of
Experimental Neurology and Medical Pharmacology, Rudolf Magnus Institute for
Neurosciences, University of Utrecht, Utrecht, The Netherlands (dorsal hemisection model).
All experiments were approved by local ethics committees on animal experimentation of both
universities.
3.2. Lesion models
3.2.1.  Dorsal Hemisection of the spinal cord
Surgical anaesthesia was induced with a mixture of O2/N2O (1:2) and 5% halothane, and was
maintained with a mixture of O2/N2O (1:2) and 2% halothane. After shaving and disinfecting
the skin with 70% alcohol, a 2 cm long skin incision was made and the dorsal part of the
spinal column was exposed by blunt dissection of the paravertebral muscles. Under a surgical
Schematic Figure 4
Schematic drawing of the spinal cord hemisection procedure (left). The hatched area in the cross section of a
spinal cord (right) indicates approximately the extent of the lesion caused by this approach.
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microscope, the dorsum of the spinal cord was exposed between thoracic levels 8 and 10
through a laminectomy. Iridectomy scissors were used to transect the dorsal half of the spinal
cord bilaterally (Houweling et al., 1998). Following the establishment of haemostasis by the
use of Spongostan (Ethicon), the wound was sutured, and the animals were allowed to
recover.
The dorsal hemisection was performed on 28 adult male Wistar rats (UWU-CPB, minimum
body weight 250 gram). Of this group, animals were sacrificed 1 day post-operation (p.o.;
n=3), 3 days p.o. (n=3), 5 days p.o. (n=3), 7 days p.o. (n=5), 14 days p.o. (n=8), 28 days p.o.
(n=3) and 56 days p.o. (n=3). Additionally, two rats were sham operated.
3.2.2. Spinal cord compression injury
Animals were anaesthetised by an intraperitoneal (i.p.) injection of xylazine (10 mg/kg body
weight) and ketalar (75 mg/kg body weight). The dorsal surface of the spinal cord was
exposed as described above, and a laminectomy was performed at level T13. The dura was
opened, and an inflatable balloon (Ingenor® Paris, model GV15) attached to a catheter was
introduced into the subdural space and moved gently to a position approximately two
segments rostral to the laminectomy (T11-T12). The balloon was then rapidly inflated with 40
µl of distilled water and left in place for five minutes. As reported by Martin and colleagues,
the inflated balloon occupies over 95% of the space in the spinal canal and effectively
Schematic Figure 5
Schematic drawing of the spinal cord compression procedure (left). The hatched area in the cross section of a
spinal cord (right) demonstrates that, by this type of injury, the complete spinal cord tissue is macerated at the
point of injury.
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macerates the tissue at the point of injury (Martin et al., 1992). The balloon was then deflated
and removed. The surgical wound was closed by suturing the three anatomical layers
(muscles, subcutaneous tissue and skin), and the animals were allowed to recover.
The surgical procedure for spinal cord compression was performed on a total of 30 rats.
Animals were sacrificed 4 days p.o. (n=1), 7 days p.o. (n=4), 14 days p.o. (n=11), 21 days p.o
(n=3) and 28 days p.o. (n=11). Additionally, ten non-operated rats were used as control
animals.
3.3. Postoperative period
To prevent urinary tract infection, animals received a daily i.p. injection of Temocillin (50
mg/kg body weight) for the first week. Furthermore, manual bladder expression was
performed twice a day until automatic bladder emptying returned (usually at the end of the
first week).
3.4. Tissue processing
At the appropriate survival time, rats were deeply anaesthetised with pentobarbital (90 mg/kg
body weight, i.p. injection) and killed by a transcardial perfusion with 0.1 M phosphate-
buffered saline (PBS, pH 7.4), followed by fixation with 500 ml of 4% paraformaldehyde
(PFA) in PBS (pH 7.4) over 20 minutes. The spinal cords were carefully dissected and post-
fixed overnight in the same fixative at 4°C. The tissue was cryoprotected at 4°C using 30%
sucrose in PBS for at least 48 hours. The lesion area of operated rats and the equivalent spinal
cord segments of non- and sham-operated animals were frozen and stored in a freezer at
-80°C. For the Western blots, 3 operated animals were re-anaesthetised at 14 dpo (3 non-
operated were used as controls) and sacrificed by a transcardial perfusion with 0.9% saline.
Samples of the spinal cord containing the lesion site were removed, frozen and stored in a
freezer at -80°C.
Material & Methods
Table 1
Monoclonal and polyclonal antibodies used for immunohistochemistry, double immunofluorescence
and Western blots. The asterisks indicate that different dilutions have been used for double
immunofluorescence and Western blots (see text).
Antigen Abbreviatio
n
Specificity Dilution Source
Neurofilament 200 kDa NF200 monoclonal 1:10.000* Sigma, Deisenhofen, Germany
Low-affinity nerve growth factor
receptor, clone 192
NGF-r monoclonal 1:50* A gift from Dr. C. Wigley
Glial fibrillary acidic protein GFAP monoclonal 1:5.000 Sigma, Deisenhofen, Germany
Complement type 3 receptor OX-42 monoclonal 1:100 Biozol, Esching, Germany
Meningococcus group B polysaccharide PSA-N-CAM monoclonal 1:500 A gift from Dr. G. Rougon
Epithelial membrane antigen EMA monoclonal 1:500* Dako Diag., Hamburg, Germany
Peripheral myelin glycoprotein P0 monoclonal 1:5.000 A gift from Dr. J. Archelos
Cell adhesion molecule L1 L1 polyclonal 1:5.000* A gift from Dr. F. Rathjen
Neural cell adhesion molecule N-CAM polyclonal 1:3.000 * Chemicon, Hofheim, Germany
S100 S100 polyclonal 1:10.000 Dako Diag., Hamburg, Germany
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3.5. Immunohistochemistry
In these studies, either serial parasagittal or longitudinal sections (10 or 20 µm thick) of the
spinal cord were prepared using a Bright cryostat. All sections were mounted on gelatine-
coated glass slides and immediately air-flow dried. Following a brief incubation in 4% PFA-
PBS (5 minutes) and several rinses in 0.1 M PBS, endogenous tissue peroxidase activity was
blocked by incubation with 0.3% hydrogen peroxide and 0.1% sodium azide in 0.1 M PBS for
15 minutes. The slides were then washed three times in 0.1 M PBS, and non-specific antibody
binding was blocked with 3% normal horse or goat serum in 0.1 M PBS containing 1%
bovine serum albumin (BSA) and 0.5% Triton X-100 (1 hour at room temperature).
Subsequently, sections were incubated with a range of primary antibodies diluted in 0.1 M
PBS containing 1% BSA. A list of all antibodies used for immunohistochemistry, double
immunofluorescence and Western blots can be seen in Table 1. After an overnight incubation
at room temperature, sections were washed three times in 0.1 M PBS and incubated with the
appropriate secondary antibody (biotinylated horse anti-mouse IgG, diluted 1:500, or
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biotinylated goat anti-rabbit IgG, diluted 1:500, Vector Laboratories, Camon Labor,
Wiesbaden, one hour at room temperature) in 0.1 M PBS (pre-absorbed with 2% normal rat
serum and containing 1% BSA). Afterwards, the sections were rinsed several times in 0.1 M
PBS and then underwent the avidin-biotin complex procedure for peroxidase staining (ABC-
Standard kit, Vector Laboratories, containing 1 drop avidin and 1 drop biotinylated
horseradish peroxidase in 5 ml PBS). To visualise the peroxidase reaction, sections were
incubated in 3,3’ diaminobenzidine (DAB, Sigma, 5 minutes), then washed in 0.1 M PBS and
counterstained with 0.02% thionin. Following dehydration in ascending concentrations of
alcohol, sections were passed through xylene and coverslipped with DPX mounting medium
(Fluka Bio Chemica, Neu Ulm). Omission of the primary antibody was used for negative
controls. The protocol for PSA-N-CAM was slightly different. PSA-N-CAM
immunohistochemistry was performed on free floating 20 µm parasagittal sections. After the
procedure for blocking endogenous peroxidase and non-specific antibody binding, sections
were incubated in the primary antibody for 48 hours at 4°C. Further processing of the tissue
was as described for the other antibodies.
The slides were visualised with a Zeiss Axioplan microscope and images stored using the
same microscope fitted with a Zeiss Axiocam camera and a Zeiss Axiovision imaging system.
3.6. Double immunofluorescence
Selected sections from each survival time were processed for double immunofluorescence to
visualise the spatial distribution of a number of antigens. NGFr/S100-, NGFr/N-CAM- and
NGFr/L1-double immunofluorescence was performed using the following staining protocol:
Non-specific binding sites were blocked with 3% normal goat serum in 0.1 M PBS containing
1% BSA and 0.5% Triton-X 100 (1 hour at room temperature). Primary antibodies were
diluted in PBS containing 1% BSA. Sections were incubated overnight in a mixture of mouse
monoclonal anti-NGFr (diluted 1:5) and rabbit polyclonal antibodies (either anti-S100,
diluted 1:10000, anti-N-CAM, diluted 1:500 or anti-L1, diluted 1:500) at room temperature.
From this point on, all incubations were performed in the dark. Secondary antibodies were
diluted in 0.1 M PBS containing 1% BSA (pre-absorbed in 3% normal rat serum). After
washing, the sections were incubated with a mixture of specific secondary antibodies (Cy™3-
conjugated goat anti-mouse IgG, diluted 1:800 and Cy™2-conjugated goat anti-rabbit IgG
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diluted 1:100; Dianova, Hamburg, 3 hours at room temperature). After several washes in
0.1% PBS, a nuclear counterstain was achieved by incubating the sections in 6 µg/ml 4’,6-
diamidino-2-phenylindole (DAPI, Sigma, 5 minutes). Sections were coverslipped using
Immunofluor mounting medium (ICN Biochemicals Inc., Eschwege).
A series of negative control experiments were performed to ensure that appropriate staining of
tissues was achieved. These experiments included both, the omission of the primary
antibodies as well as single stains, which combined the polyclonal rabbit primary antibodies
with the secondary anti-mouse antibodies and the monoclonal mouse primary antibodies with
the secondary anti-rabbit antibodies.
Sections were examined using a Zeiss Axioplan microscope. Images were prepared using a
Zeiss inverted microscope fitted with a BIO-RAD MRC1024 laser scanning imaging system.
An Argon-Krypton laser beam was used with excitation at 488 nm for Cy™2 visualisation
and 586 nm for Cy™3 visualisation. Single confocal plane images (786 x 512 pixels) were
collected with the laser in slow scanning mode with Kalman filtering. High magnification
images were obtained using a 40 x Plan-Neofluor oil immersion objective lens.
EMA double immunofluorescence required an alternative protocol for revealing the presence
of the antigen. The CY™-conjugated secondary antibodies did not recognise the anti-EMA
primary antibody, due to its specific isotype (IgG2a kappa). Therefore a streptavidin
intermediate step had to be performed which allowed the use of two monoclonal primary
antibodies. Non-specific binding sites were blocked with 3% normal goat serum in 0.1 M
PBS containing 1% BSA and 0.5% Triton-X 100 (1 hour at room temperature). Following the
overnight incubation with the mouse monoclonal anti-EMA antibody (diluted 1:50 in 0.1 M
PBS), sections were incubated with a biotinylated horse anti-mouse IgG antibody (Vector
Laboratories), diluted 1:500 in 0.1M PBS containing 1% BSA and 3% normal rat serum (1
hour at room temperature). Five washes in 0.1 M PBS were followed by an overnight,
incubation in the second primary mouse monoclonal antibodies (either anti-NGFr diluted 1:5,
anti-NF200 diluted 1:5000, anti-P0 diluted 1:5000 in 0,1M PBS) at room temperature.
From this point on, all incubations were performed in the dark. After several washes, the
sections were incubated for 3 hours at room temperature with a mixture of Cy™3 conjugated
Streptavidin (Dianova) diluted 1:1000 and Cy™2-conjugated goat anti-mouse IgG diluted
1:100 in 0.1 M PBS containing 1% BSA (pre-absorbed with 3% normal rat serum). After
several washes, a nuclear counterstain as well as coverslipping was performed as described
above.
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Negative control experiments included omission of primary antibodies and also single stains,
which combined the monoclonal EMA antibodies with the secondary Cy™2-conjugated goat
anti-mouse IgG antibodies and the other monoclonal mouse primary antibodies with the
Cy™3 conjugated Streptavidin. Sections were examined using a Zeiss Axioplan microscope
fitted with a HBO 50 mercury lamp and a filter block I and II with excitation at 488 nm for
Cy™2 visualisation and 586 nm for Cy™3 visualisation. Standard epifluorescence images
were stored using the same microscope fitted with a Zeiss Axiocam camera and Zeiss
Axiovision imaging system. High magnification images were obtained using a 40 x Plan-
Neofluor oil immersion objective lens.
3.7. Western blots
Fresh frozen spinal cord tissue samples from 3 operated and 3 control animals were processed
individually, according to the method described by Chanas-Sacré et al. (Chanas-Sacré et al.,
1999).
3.7.1. Preparation of protein extracts
Pieces of lesioned and normal spinal cord (approximately 100-150 mg) were homogenised in
50 mM extraction buffer. This buffer contained 5 mM ethylene glycol tetraacetic acid
(EGTA), a chelator of calcium and magnesium, 5 mM benzamidine, 5 mM N-ethylene
maliamide, and 1/500 of the total volume of phenlmethylsulphonyl fluoride in 0.05 M Tris
buffer (pH 6.8) for protease inhibition. After ultracentrifugation at 4°C for 15 minutes at
60.000 RPM, the supernatant, containing proteins in the soluble fraction, was collected. An
equal volume of extraction buffer, this time containing 2% sodium dodecyl sulphate (SDS),
was added to the insoluble fraction, which was then re-suspended and re-homogenised. After
centrifugation (under the same conditions as above), the supernatant, containing membrane-
bound and cytoskeletal proteins, was collected.
Protein concentrations of samples were assessed by the method described by Fryer et al.
(Fryer et al., 1986) to facilitate the loading of an equal amount of sample protein onto each
lane for electrophoresis. The protein samples were diluted 1:4 with a solution containing 75%
loading buffer (Tris, pH 8.0, EGTA and SDS), 25% ß-mercaptoethanol and a few crystals of
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bromophenol blue. In order to denature the proteins and thereby facilitate their mobility, the
samples were boiled for 2 minutes at 100°C prior to being loaded onto the gel.
3.7.2. Electrophoresis
A volume of 1 µl of each sample and also of a standard molecular weight protein solution
(Bio-Rad Laboratories, Nazareth, Belgium) was applied to a 4-15% gradient polyacrylamide
Phastgel (Amersham Pharmacia Biotech, Freiburg) which then ran for 45 minutes at room
temperature. To transfer the proteins from the gel to a polyvinylidine difluoride membrane,
the membrane was hydrated and placed against the gel. The electrophoretic transfer of
proteins was then run for 15 minutes at room temperature.
3.7.3. Immunostaining
After incubation in a blocking solution of Tween-TBS (TTBS) containing 0.05% Tween-20
(Bisra) and 3% gelatine in Tris buffered saline (TBS), the membranes were incubated
overnight at 4°C with either the polyclonal anti-N-CAM antibodies or the polyclonal anti-L1
antibodies (both diluted 1:500). After 4 x 10 minute washes in TTBS, the membranes were
incubated with a biotinylated pig anti-rabbit antibody (Jackson Laboratories) diluted 1:2000
in TTBS (37°C, 1 hour). After another 4 x 10 minute washes in TTBS, the membranes were
incubated in horseradish peroxidase-conjugated streptavidin (diluted 1:100.000 in TTBS,
Boehringer Mannheim Biochemicals, Brussels, Belgium, 1 hour). The membranes were again
washed 4 times in TTBS, incubated in a developing solution containing 20 mg
tetramethylbenzidine and 40 mg dioctyl-sulfo-succinate (in 1 ml NN-dimethylformamide),
diluted in 50 ml acetate buffer pH 6.0 (2,85 ml acetic acid and 200 mg Na-perborate per 1L
distilled water).
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4. Results
4.1. Part 1: Immunohistochemical detection of the cell adhesion molecules L1 and
N-CAM after dorsal hemisection of the rat spinal cord
General comments: In this part of the investigation, a dorsal hemisection of the lower
thoracic spinal cord was performed on a total of 28 rats. None of the rats died during the
surgical procedure and all animals developed an acute paralysis of the lower limbs. A distinct
locomotor recovery, i.e. the ability to make hindlimb movements, could be observed in most
rats by 1-2 weeks p.o. The lesion site was generally characterised by the involvement of the
dorsal funiculus and the dorsolateral funiculi on both sides, as well as the grey matter of the
dorsal horn. The central canal and the ventral parts of the spinal cord were usually not
affected by the trauma. The extent of the lesion varied slightly from animal to animal.
Western blots: Western blots from both normal and lesioned spinal cord tissue (14 days p.o.)
were performed to verify the specific recognition of L1 and N-CAM antigens by the
antibodies used in these experiments (Fig. 1). A single band of specific staining with an
apparent molecular weight of approximately 190 kDa was identified by the polyclonal anti-L1
antibody (large arrow in Fig. 1). Three distinct bands of proteins of relative molecular weights
of approximately 115, 138 and 177 kDa appeared to be stained using the polyclonal N-CAM
antibody (small arrows in Fig. 1).
One day p.o.: Following dorsal hemisection of the spinal cord, the lesion site could be readily
identified by NF200-immunohistchemistry. In parasagittal sections, the non-stained injury site
(black asterisk in Fig. 2A) was clearly delineated by strongly stained NF200-positive axonal
profiles at the borders of the lesion. Higher magnification of this region revealed the
interruption of the axonal integrity (Fig. 2B). Numerous severed axons with rounded terminal
swellings, so-called ”retraction-bulbs” (arrows in Fig. 2B), could be detected at the junction
between the lesion and the normal white matter. Axonal fragments and scattered axonal
debris could also be observed within the injured area.
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Figure 1
Summary of Western blot demonstration of L1 and N-CAM from unlesioned and lesioned spinal cords. The lanes are
indicated as follows: Co: negative control (primary antibody omitted from the incubation); L1: blot incubated with
polyclonal anti-L1 antibody; NCAM: blot incubated with polyclonal anti-N-CAM antibody; St: molecular weight standard.
The values for individual bands are indicated in kDa. The detection of bands for L1 and N-CAM were essentially identical
for both control and lesioned spinal cord preparations.
A single band of specific staining with an apparent molecular weight of approximately 190 kDa is demonstrated by the anti-
L1 antibody (large arrow). Three bands of specific staining with apparent molecular weights of approximately 115, 138 and
177 kDa are identified by the anti-N-CAM antibody (small arrows). The other weaker bands were also found in the negative
control and are probably due to the presence of intrinsic biotin.
Immunostaining with antibodies directed against the cell adhesion molecules L1 and N-CAM
also presented a clearly delineated lesion site (e.g. black asterisks in Fig. 2C and D). Apart
from some stained debris, no L1- or N-CAM-immunoreactive profiles could be seen within
the lesion site. However, strong L1- and N-CAM-immunoreactivity could be observed in the
adjacent intact spinal cord parenchyma. The grey matter of control (e.g. white asterisk in Fig.
2E for L1) and the lesioned spinal cord (white asterisks in Fig. 2C and D) was characterised
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Figure 2A-F (page 30)
Parasagittal sections displaying the pathological consequences of dorsal hemisection of the spinal cord at 1 day
p.o., except for Fig. 1E which shows an unlesioned spinal cord. (A) The lesion site (black asterisk) is clearly
fenced by the NF200-staining of axons in the adjacent intact spinal cord. (B) Swollen NF200-positive
”retraction bulbs” (arrows) can be seen at the severed ends of the nerve fibres at the lesion interface. (C) The
injury site (black asterisk) is also clearly delineated by intense L1-immunoreactivity in the surrounding
unlesioned grey matter (white asterisk). The lesion site only contains a small amount of L1-positive debris and
in the ventral fasciculus, longitudinally orientated, small calibre nerve fibres can bee seen (arrowheads). (D)
Immunostaining with anti-N-CAM antibodies displays a similar distribution. Strong N-CAM-immunoreactivity
is detectable in the intact grey matter (white asterisk) adjacent to the lesion site, while in the lesion site itself
(black asterisk) no specific staining appears, apart from N-CAM-positive debris. (E) Distribution of L1-
immunoreactivity in the unlesioned spinal cord. L1-positive nerve fibres (arrowheads) can be detected in the
white matter (black asterisk), while a more diffuse staining appears in the grey matter (white asterisk). No
specific L1-immunoreactivity can be seen in the meninges (arrows). (F) The lesion site (black asterisk) is not as
readily to identify by PSA-N-CAM immunostaining. PSA-N-CAM-immunoreactivity of quite granular quality is
only detectable in the superficial region of the dorsal horn (large arrows) and in the dorsal most part of the
ventral white matter, where a few small calibre profiles can bee seen (small arrows). Thionin counterstain in all
sections.
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by a diffuse quality of staining for both antigens. In the white matter, L1-positive nerve fibres
appeared as longitudinally orientated small calibre profiles (arrowheads in Fig. 2C and E).
Immunohistochemistry with anti-PSA-N-CAM antibodies displayed a different pattern of
staining (Fig. 2F). PSA-N-CAM-positive profiles could only be detected in the superficial
lamina of the dorsal horn and dorsal most part of the ventral funiculus. In the dorsal horn, a
more granular quality of staining could be observed (large arrows in Fig. 2F), while in the
ventral funiculus, only a few longitudinally orientated structures appeared (small arrows in
Fig. 2F).
Immunostaining with anti-GFAP antibodies clearly demonstrated the interruption of the
astrocytic network at the site of injury (Fig. 3A). GFAP-positive glial processes consistently
ended at the lesion edge and did not enter the injured area (black asterisk in Fig. 3A). The
lesion site itself consisted of necrotic cellular, axonal and myelin debris scattered amongst
numerous inflammatory cells (arrows in Fig. 3B) and occasional erythrocytes (arrowheads in
Fig. 3B). Typical polymorphnuclear neutrophils (arrows in Fig. 3B) accumulated within the
necrotic tissue. OX-42-positive phagocytic microglia/macrophages (arrows in Fig. 3C) were
mainly located at the lesion interface by 1 day p.o. (asterisk in Fig. 3C). The asterisks in
Figures 3D-E indicate local spinal nerve roots that have also been injured during the surgical
procedure. NGFr-Immunohistochemistry demonstrated only occasional NGFr-positive
cellular elements (probably de-differentiated Schwann cells) in the nerve roots at this survival
time (arrows in Fig. 3D). Immunohistochemistry with anti-L1- or anti-N-CAM antibodies
revealed a comparable pattern of immunoreactivity to that of NGFr in the damaged
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Figure 3A-F (page 32)
Further pathological consequences of dorsal hemisection of the spinal cord (A-C) and the local spinal nerve
roots (D-E) at one day p.o. (A) The interface between the intact spinal cord (white asterisk) and the injured
tissue (black asterisk), which has been washed out during the tissue preparation, is well delineated by an
interwoven network of GFAP-positive astrocytes and astrocytic processes. (B) Numerous thionin-stained,
polymorphnuclear neutrophils (arrows) have infiltrated the lesion site. Occasional erythrocytes (arrowheads) can
also be detected in the injured tissue. (C) Adjacent section to that shown in A; activated OX-42-positive
phagocytic microglia/macrophages (arrows) accumulate at the lesion interface (asterisk). (D) NGFr-
immunoreactivity in a part of a damaged spinal nerve root (black asterisks) lying on the surface of the spinal
cord (white asterisks). Occasional NGFr-positive profiles can be detected within the root (arrows). A
comparable staining pattern with occasional immunoreactive longitudinally orientated profiles (arrows) can be
seen in damaged nerve roots (black asterisks) processed with anti-L1 (E) and anti-N-CAM antibodies (F). The
white asterisks indicate the spinal cords in both figures. Thionin counterstain in A, B, D-F.
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nerve roots (Fig. 3E and F). The staining pattern for all three antigens at this survival time
was quite similar to that seen in unlesioned spinal nerve roots (not shown).
Three to 5 days p.o.: A massive increase of NGFr-immunoreactivity in the damaged spinal
nerve roots could already be observed at 3 days p.o. (large arrows in Fig. 4A). At this survival
time, numerous strongly NGFr-positive profiles also appeared in the lesioned area, mostly
concentrated on the dorsal surface near the dorsal root entry zone (arrowheads in Fig. 4A). In
the more ventral regions of the lesion, individual NGFr-positive cells could also occasionally
be observed. Close inspection of this area (Fig. 4B, which represents a higher magnification
of the boxed area shown in Fig. 4A) revealed the morphology of the stained cells. Many of
them displayed a bipolar, spindle-shaped morphology with an ovoid nucleus, typical of
migrating, de-differentiated Schwann cells (arrows in Fig. 4B). At this survival time, a
significant number of the labelled cells had already adopted an orientation parallel to the
longitudinal axis of the spinal cord. Increased L1- and N-CAM-immunoreactivity was also
detected in the damaged spinal nerve roots (not shown), and the lesion site had already
become infiltrated by several L1- and N-CAM-positive profiles (not shown).
Despite clear indications of non-neuronal cell migration into the lesion, none of these cells
were GFAP-positive. At 5 days p.o., the astrocytic network at the lesion interface appeared to
be slightly hypertrophied and showed a moderate increase of GFAP-immunoreactivity (Fig.
4C). However, no significant penetration of the lesion site by these astrocytes could be
observed.
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Figure 4A-F (page 34)
Early axonal and glial infiltration into the lesion site at 3-5 days p.o. (A) Overview of the lesion site,
demonstrating moderate invasion by NGFr-positive profiles at 3 days p.o. The lesion interface is marked by the
dashed line. A massive increase of NGFr-immunoreactivity can be observed in the damaged local spinal nerve
root (large arrows). NGFr-positive profiles seem to be accumulated at the dorsal surface of the lesioned spinal
cord near the dorsal root entry zone (arrowheads). In the deeper parts of the lesion, scattered NGFr-positive
structures can also be seen. On the ventral surface of the spinal cord, the meninges appear as intensely NGFr-
positive band (small arrows) (B) Higher magnification of the boxed area in Fig. 3A. Occasional NGFr-positive
bipolar, spindle-shaped cells (arrows) appear deep within the lesion site. (C) Network of GFAP-positive,
slightly hypertrophied astrocytes at the lesion interface. There is no formation of an astrocytic barrier nor is there
an astrocytic penetration into the lesion site (black asterisk). (D) Close to the lesion interface, a small calibre
NF200-positive axonal sprout (arrowheads) can be detected extending from the severed end of a large calibre
axon (arrow) into the lesion site at 5 days p.o. (E) Deep within the lesion, occasional, uniform small-calibre
NF200-positive axonal sprouts (arrows) can be seen running in parallel with longitudinally orientated thionin-
stained glial nuclei (small arrowheads). Many of these nuclei appear to be longitudinally orientated prior to the
association with re-growing axons. The large arrowheads indicate the thionin-stained nuclei of
macrophages/microglia within the lesion. (F) At 5 days p.o., numerous OX42-positive rounded
macrophages/microglia have invaded the lesion site. Thionin counterstain in A-C, E.
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In contrast, several small calibre NF200-positive axonal sprouts could be seen extending from
the adjacent intact spinal cord into the lesion site (Fig. 4D). In some cases, the fine axonal
sprouts (e.g. arrowheads in Fig. 4D) could clearly be seen extending from the severed ends of
larger diameter nerve fibres (arrow in Fig. 4D). Although such axonal sprouts penetrated the
lesion for several hundred microns, only a small number of NF200-positive axons could be
observed in the centre of lesion (arrows in Fig. 4E). The axonal sprouts seemed to be
associated with the thionin-counterstained, longitudinally orientated glial cells in the lesion
(small arrowheads in Fig. 4E).
The inflammatory response to the injury also developed in the lesioned area. There was a
clear reduction in the number of polymorphnuclear neutrophils at 5 days p.o. (Fig. 4E). It
seemed that these cells had been replaced by phagocytic macrophages/microglia, showing
small thionin-stained nuclei (large arrowheads in Fig. 4E) and OX-42-immunoreactivity (Fig.
4F). These cells, which had only accumulated at the lesion interface by 1 day p.o., were now
densely packed within the entire lesion site.
At this survival time, the lesion site had already been massively infiltrated by L1- and N-
CAM-positive profiles (Fig. 5A and 5C, respectively). Higher magnification of the injury site
demonstrated that several of the stained cellular structures displayed the same bipolar,
spindle- shaped morphology as had already been identified by NGFr-immunohistochemistry
(e.g. arrow in Fig. 5B for L1-, and in Fig. 5D for N-CAM-immunohistochemistry).
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Figure 5 (A-E)
Immunohistochemical detection of the cell adhesion molecules L1, N-CAM and PSA-N-CAM in the lesion site at 5 days 
p.o. (A) Numerous fine L1-positive profiles can be detected within the lesion site. (B) Higher magnification reveals that 
L1-immunoreactivity can be found on spindle-shaped cells with an ovoid nucleus (arrow). (C) Numerous intensely N-
CAM-positive profiles can also be seen within the lesion. (D) N-CAM-positive, bipolar, spindle-shaped cell (arrow) of 
similar size and orientation as that shown in B. (E) Only occasional PSA-N-CAM-positive profiles of uniform, small 
calibre (arrows) can be observed scattered amongst numerous, longitudinally orientated thionin-stained cells and 
macrophages in the lesion site. Thionin counterstain in C-E 
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Figure 6 A-F (page 37)
Massive infiltration of the lesion site by NGFr-, L1- and N-CAM-positive structures at 14 days p.o. The
micrographs of the right column represent higher magnifications of the boxed areas in the micrographs shown
on the left side. (A) The entire lesion site has been filled by a network of NGFr-positive profiles. (B) Higher
magnification shows that the framework adopted an overall longitudinal orientation and mainly consists of
bundles of NGFr-immunoreactive cell bodies and processes (arrowheads). Single NGFr-positive profiles can
also be observed (arrows). (C) Adjacent section to that shown in A processed for L1-immunohistochemistry.
L1-positive profiles also form a longitudinally orientated network within the territory of the lesion. (D) Higher
magnification demonstrates that L1-positive profiles course throughout the lesion as large bundles (arrowheads)
and single cells (arrows). (E) Adjacent section to that shown in A and C. An immunoreactive framework within
the lesion site can also be detected by N-CAM-immunohistochemistry. (F) Higher magnification reveals that the
longitudinally orientated framework is formed by individual cells (arrows) and bundles (arrowheads) of closely
packed N-CAM-positive profiles. Thionin counterstain in A-F.
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In contrast to the distinct infiltration of L1-and N-CAM-positive structures, only occasional
PSA-N-CAM-positive profiles could be observed in the lesion site. A weak and granular
staining for PSA-N-CAM was detectable on some longitudinally orientated profiles (arrows
in Fig. 5E), which were of uniformly small calibre and scattered amongst the numerous
thionin- stained cells of the lesion.
Seven to 14 days p.o: Between 7 and 14 days p.o., the entire lesion site had been filled by an
interwoven network of NGFr-positive cells (Fig. 6A). As NGFr-positive structures were not
detectable in the adjacent intact spinal cord parenchyma, this framework clearly demarcated
the borders of the lesion site. In the superficial regions, the network seemed to be more
compact than in the deeper areas of the lesion. Higher magnification revealed that the
framework consisted mainly of closely packed bundles of overlapping cell bodies and
processes (arrowheads in Fig. 6B), as well as of some individual, spindle-shaped cells (arrows
in Fig. 6B). Although this framework was quite irregular, its principal orientation appeared to
be parallel to the longitudinal axis of the spinal cord.
The progressive increase in the amount of NGFr-expression in the lesion site closely
correlated with an increase in the number of L1- and N-CAM-positive profiles (Fig. 6C-F).
The amount of L1- and N-CAM-positive cells, their spatial pattern and orientation were
impressively similar to that already observed by NGFr-immunohistochemistry. The
framework also consisted of bundles of L1- and N-CAM-positive profiles (arrowheads in Fig.
6D and F, respectively) apart from occasional individual spindle-shaped cells (e.g. arrows in
Fig. 6D and F).
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Figure 7 (A-D)
Infiltration of the lesion site by astrocytes and axons at 14 days p.o. (A) Overview of the lesion 
interface. A strong GFAP-positive network of hypertrophied reactive astrocytes can be seen in the 
intact spinal cord parenchyma (black asterisk). "Flares" of longitudinally orientated, GFAP-positive 
astrocytic processes seem to penetrate the lesion site for several hundred microns (arrows). (B) 
Higher magnification reveals that these GFAP-positive processes (arrows) are closely intermixed 
and in continuity with longitudinally orientated bundles of GFAP-negative, thionin-stained cells 
(arrowheads) within the lesion site. (C) Individual NF200-positive nerve fibres (large arrowheads), 
as well as large fascicles of NF200-positive axons (arrows) can be detected, traversing the gap 
between the intact spinal cord parenchyma (asterisk) and the territory of the lesion. The axonal 
profiles within the lesion site mostly adopt an longitudinal orientation but occasional "U-turns" can 
also be observed (small arrowhead). (D) High magnification from a deeper part of the lesion 
demonstrates that many NF200-positive axons retain their longitudinal orientation (arrows), as well 
as their intimate association with longitudinal orientated thionin stained cells (large arrowheads). 
An axonal "U-turn" can also be seen in this part of the lesion (small arrowhead). Thionin 
counterstain in A-D.
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Up to this survival time, no GFAP-immunoreactivity had been detected far within the
lesion site. At the lesion interface, a network of hypertrophic, strongly GFAP-positive
astrocytes could be observed. However, this astrocytic network remained ”open” to the
territory of the lesion. There was no evidence of an astrocytic barrier in form of a dense
overlap or a coalescence of the astrocytic processes. ”Flares” of longitudinally orientated
GFAP-positive astrocytic processes now penetrated the lesion site for distances of up to a
few hundred microns. These long slender processes (arrows in Fig. 7A and B) were
intimately intermixed with bundles of longitudinal orientated GFAP-negative, thionin-
stained glial cells. Deeper within the lesion, the bundles consisted only of these GFAP-
negative spindle-shaped glial cells (e.g. arrowheads in Fig. 7B). This behaviour led to the
impression that the transition from the intact spinal cord parenchyma to the lesioned area
was not sharply delineated but more associated with a ”transition area” of mixed CNS
astrocytic processes and PNS Schwann cell and/or leptomeningeal cell processes.
By now, a substantial number of NF200-positive axons could be detected in the lesion site.
At the lesion interface, many longitudinally orientated NF200-positive axons could be
seen traversing the ”transition area” between the intact and lesioned spinal cord.
Individual nerve fibres (large arrowheads in Fig. 7C), as well as large fascicles of stained
axons (arrows in Fig. 7C) entered the lesion site from both, the rostral and caudal spinal
cord tissue. Qualitatively, there was no difference in the amount of axons crossing either
the proximal or distal lesion interface. Many of these re-growing axons coursed
throughout the lesion site and remained closely associated with longitudinally orientated
thionin-stained cells (large arrowheads in Fig. 7D). Occasional axons undergoing ”U-
turns” could also be observed (small arrowheads in Fig. 7C and D).
Double immunofluorescence: Double immunofluorescence was performed to obtain a
clearer identification of the non-neuronal, NGFr-positive cells in the lesion site. The
different staining patterns of de-differentiated Schwann cells in damaged nerve roots and
leptomeningeal cells in the normal pia mater were compared with the equivalent staining
patterns in the lesioned spinal cord. De-differentiated Schwann cells within damaged
dorsal roots demonstrated intense immunoreactivity for NGFr and S100 (orange profiles,
arrows in Fig. 8B). These cells were also L1- and N-CAM-positive (not shown).
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Figure 8A-F (page 41)
Double immunofluorescence for the identification of Schwann cells in activated dorsal nerve roots, and
leptomeningeal cells on the pial surface in lesioned (A, B and E, 7 days p.o.) and control (C, D and F) spinal
cords. NGFr-immunoreactive profiles are always demonstrated by Cy-3 fluorescence (red). Other antigens (L1,
N-CAM, S100) are demonstrated by Cy-2 fluorescence (green). Strong spatial correlation of antigens is revealed
by resulting orange/yellow colour. (A) Spatial correlation of NGFr- and S100-immunoreactivity in an activated
dorsal nerve root at 7 days p.o. Strong S100-immunoreactive astrocytes can be observed in the adjacent spinal
cord (asterisk). (B) Higher magnification of the dorsal nerve root shown in A, clearly demonstrates the intimate
proximity of both antigens on de-differentiated Schwann-cells, resulting in orange colour (arrows). (C) and (D)
Examples of leptomeningeal cells of the pial surface which appear to be both NGFr- and N-CAM-positive
(arrows). Neural structures in the adjacent spinal cord (asterisks) show a strong N-CAM-immunoreactivity. (E)
NGFr-positive leptomeningeal processes at the pial surface remain L1-negative (red, arrows). In the spinal cord
(asterisk) L1-positive/NGFr-negative axonal profiles can be seen, whereas occasional L1-/NGFr-positive de-
differentiated Schwann cells can be detected in the adjacent activated spinal nerve root (arrowheads). (F) An
intensely NGFr-positive leptomeningeal cell (red, arrows) on the pial surface lies in close proximity to S100-
positive astrocytes (green, asterisk) of the spinal cord.
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A different pattern of immunoreactivity was detectable on the leptomeningeal cells of the pial
surface. Those cells were also strongly immunoreactive for NGFr and N-CAM (yellow
profiles, arrows in Fig. 8C and D), but they were L1-negative (red profiles, arrows in Fig. 8E)
and S100-negative (red profiles, arrows in Fig. 8F). A summary of the staining patterns of de-
differentiated Schwann cells and leptomeningeal cells is given in Table 2 (see below).
This staining pattern revealed that numerous NGFr-/S100-positive (orange profiles, arrows in
Fig. 9A and B) and NGFr-/L1-positive Schwann cells (yellow profiles, arrows in Fig. 9C and
D) could be detected in the lesion site at 7 days p.o.
However, some NGFr-positive/S100-negative leptomeningeal cells (red profiles, arrows in
Fig. 10A and B), which were also NGFr-positive/L1-negative (red profiles, arrowheads in
Fig. 9C, arrows in Fig. 10C and D), could also be seen intermingled between the Schwann
cells. Qualitatively, the number of Schwann cells in the lesion site was significantly higher
than that of leptomeningeal cells.
At the later survival times (28-56 days p.o.), relatively few NGFr-/L1-positive profiles
(interpreted as being de-differentiated Schwann cells in the early survival times; see
discussion) were detectable. At these survival times, L1-immunoreactivity was mostly
associated with long slender profiles of uniform calibre (probably axons), which were always
in close contact with NGFr-positive cells (not shown). NGFr-negative/S100-positive
astrocytic profiles (arrowheads in Fig. 10B) could also be seen intermingling with
leptomeningeal cells and Schwann cells at the lesion interface. No differentiation of the cell
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Figure 9 (A-D)
Double immunofluorescence to identify Schwann cells and leptomeningeal cells in the lesioned spinal 
cord. (A) and (B) Examples of NGFr-/S100-positive Schwann cells (arrows) and processes 
(arrowheads) deep within the territory of the lesion at 14 days p.o. (C) Schwann cells within the lesion 
site can also be detected by double immunofluorescence with anti-NGFr and anti-L1 antibodies at 14 
days p.o. The close spatial correlation can be seen on spindle-shaped cells and their long slender 
processes (arrows). A leptomeningeal process in the same area is NGFr-positive and L1-negative 
(arrowheads). (D) Co-localisation of NGFr- and L1-immunoreactivity on an individual spindle-shaped 
Schwann cell (arrows) close to a bundle of NGFr-/L1-positive Schwann cells and processes 
(arrowheads) at 28 days p.o.
43
A B
D
FE
C
Results
Figure 10 (A-F)
44
(Legend see page 45)
Results
Figure 10 A-F (page 44)
Double immunofluorescence reveals the participation of leptomeningeal cells in the non-neuronal cell invasion
of the lesion site (A-D) and the co-localisation of NGFr and N-CAM on all non-neuronal cells within the lesion
site at 28 days p.o. (E and F). (A) An individual NGFr-positive spindle-shaped leptomeningeal cell (red, arrows)
deep within the centre of the lesion remains S100-negative. (B) At the lesion interface, intensely NGFr-
positive/S100-negative leptomeningeal cells and processes (red, arrows) can be detected near S100-
positive/NGFr-negative astrocytic processes (green, arrowheads) at 21 days p.o. (C) A single NGFr-positive/L1-
negative leptomeningeal cell (arrow) can be seen in the deeper parts of the lesion site at 14 days p.o. (D) At 28
days p.o., NGFr-positive/L1-negative leptomeningeal cells (red, arrows) can be seen intermingled with NGFr-
/L1-positive Schwann cells and processes (yellow, arrowheads). (E) Overview of an area deep within the
lesioned territory. All NGFr-positive cellular profiles co-express the cell adhesion molecule N-CAM. (F) Higher
magnification reveals the co-localisation of both antigens on the cell body and processes of an individual spindle
shaped cell (arrows).
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type in the lesion could be made by double-staining for NGFr/N-CAM. All NGFr-positive
Schwann cells and leptomeningeal cells within the lesion site displayed a clear N-CAM-
immunoreactivity (arrows in Fig. 10E and F).
Table 2
Immunohistochemical profile of de-differentiated Schwann cells in damaged spinal nerve roots and
leptomeningeal cells of the pia mater of the spinal cord. Both, Schwann cells and leptomeningeal
cells appeared to be NGFr- and N-CAM-positive. However, L1- and S100-immunoreactivity was
only detectable on Schwann cells, while leptomeningeal cells remained L1- and S100-negative.
NGFr N-CAM L1 S100
De-differentiated Schwann cells + + + +
Leptomeningeal cells + + - -
Twenty-eight to 56 days p.o.: At the longer survival times (28-56 days p.o.), the lesion site
was still clearly demarcated by the NGFr-positive network of Schwann cells and
leptomeningeal cells. However, in contrast to the shorter survival times, an overall
longitudinal orientation of this framework was no longer detectable. A shift to a more ventro-
dorsal orientation took place between 28 and 56 days p.o. (compare Fig. 11A and 12A).
In the same period, a comparable change in the orientation of NF200-positive axons also
became apparent within the lesion (compare Fig. 11B and 12B). There was no indication of
axonal degeneration or neurofilamentous debris in the lesion at these later survival times. On
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Figure 11 (A-D)
Axonal and glial infiltration of the lesion site at 28 days p.o. (A) Intensely stained longitudinally 
orientated NGFr-positive profiles can be detected in the territory of the lesion at 28 days p.o. (B) 
Numerous longitudinally orientated NF200-positive axonal profiles can also still be observed in the 
lesion site. (C) The L1 staining pattern within the lesion site closely resembles the staining pattern for 
NGFr and NF200. (D) The network of reactive astrocytes (asterisk) still extends long processes into 
the lesion site. These processes become intimately mixed with thionin stained cells of the lesion site. 
Thionin counterstain in A-D.
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Figure 12A-F (page 47))
Long-term pattern of glial and axonal invasion of the lesion site. (A) At 56 days p.o., an increased number of
NGFr-positive profiles is detectable in the territory of the lesion. The orientation of these profiles switched from
overall longitudinal to more dorso-ventral. (B) NF200-immunohistochemistry reveals a comparable
phenomenon for the axonal profiles in the lesion site. An increased number of now dorso-ventrally orientated
NF200-positive axons can be detected. (C) As at the earlier survival times, the pattern of the L1-positive profiles
closely resembles the pattern and orientation of NGFr- and NF200-positive profiles within the lesion. (D) The
lesion site of one animal is nearly completely composed of a chambered cystic cavity (asterisks). The borders of
this cavity are closely fenced by reactive, GFAP-positive astrocytes. A typical connective tissue scar can only be
seen in a small area in the middle of the lesion (arrows). (E) and (F) PSA-N-CAM-immunoreactivity can still
only be detected on occasional profiles within the lesion site at 56 days p.o. Relatively strong PSA-NCAM-
staining is associated with long slender profiles of uniform calibre (arrows). A weaker and more granular quality
of staining can be seen on individual spindle-shaped cells and cell bundles (arrowheads). Thionin counterstain in
A-F.
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the contrary, it seemed that the number of both, NF200-positive axons and NGFr-positive
cells in the lesion site had actually increased between 28 and 56 days p.o.
In one animal, an increase of axonal and cellular profiles in the lesion site could not be
observed. In this case, the territory of the lesion was nearly completely occupied by an
extended and chambered cystic cavity (asterisks in Fig. 12D). GFAP-immunohistochemistry
revealed that the cavity was closely surrounded by reactive astrocytes (Fig. 12D). Where
cystic cavitation did not occur, interdigitating GFAP-positive astrocytic processes and GFAP-
negative, thionin-stained cells could still be detected at the interface between the intact spinal
cord parenchyma and the lesioned area (e.g. Fig. 11D).
In the animals, where a substantial connective tissue scar could still be seen, there was a
strong spatial correlation between NGFr-immunoreactivity and L1-/N-CAM-
immunoreactivity (Fig. 11C and 12C for examples of L1-staining). Despite the widespread
presence of L1- and N-CAM-positive profiles at the later survival times, only occasional
PSA-N-CAM-positive structures could be seen scattered among numerous thionin-stained
cells of the lesion site. At 56 days p.o., PSA-N-CAM-immunoreactivity was detectable on
long slender profiles (probably axons, arrows in Fig. 12E), as well as on occasional spindle-
shaped cells and cell bundles (probably glial cells, arrowheads in Fig. 12E and F).
Results
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4.2.    Part 2: Immunohistochemical detection of epithelial membrane antigen (EMA) in
the intact and lesioned spinal nerve root and spinal cord
4.2.1. General comments
For these studies, 30 rats underwent the surgical compression of the lower thoracic spinal
cord. All of the rats survived the operation without complications. Functionally, this type of
trauma resulted in an acute and severe paraplegia of the lower extremity. None of the rats
showed a substantial locomotor improvement during the four weeks investigation period.
Local spinal nerve roots near the area of the lesion were also damaged by this type of injury.
4.2.2. Characteristic features of EMA-positive structures in the normal spinal cord and
spinal nerve roots
4.2.2.1. EMA-immunoreactivity
EMA-immunoreactivity was not detectable in the unlesioned spinal cord, neither in the white
matter (black asterisks in Fig. 13A and B), nor in the grey matter (white asterisk in Fig. 13A
and B). Neuronal cell bodies (arrows in Fig. 13B), central glial cells (small arrowheads in
13B), ependymal cells of the central canal (small arrowheads in 13A), as well as the wall of
small vessels (large arrowheads in Fig. 13A and B) within the spinal cord were all EMA-
negative.
On the contrary, intensely EMA-positive structures were detected in local spinal nerve roots
(Fig. 13C-E) and in dorsal root ganglia (Fig. 13F and G). Surprisingly, EMA-
immunoreactivity did not seem to be associated with perineurial structures but more with
structures resembling myelinating Schwann cells. In transverse sections of the nerve roots,
strong EMA-immunoreactivity was detectable on ring-like structures of variable calibres (Fig.
13D and E). The outer diameter of these structures ranged from approximately 3 to 15
microns, and the distance between the outer and inner surface measured approximately 1 to 2
microns. The outer sheath of the spinal nerve roots showed no EMA-immunostaining (arrows
in Fig. 13C and D), and there was no evidence of EMA-positive perineurial-like structures.
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Figure 13A-G (page 50)
EMA-immunostaining in the unlesioned spinal cord (A and B), in unlesioned spinal nerve roots (C-E) and in a
dorsal root ganglion (F and G). (A) and (B) In the normal, unlesioned spinal cord EMA-immunoreactive
structures are detectable neither in the white matter (black asterisk) nor in the grey matter (white asterisks).
Neuronal cell bodies (arrows), central glial cells (small arrowheads in B), ependymal cells of the central canal
(small arrowheads in A) and the wall of small vessels (large arrowheads) are all EMA-negative. (C)
Longitudinal section of a normal spinal nerve root (white asterisk) lying on the surface of the spinal cord (black
asterisk). EMA-immunoreactivity appears on the outer surface of longitudinally orientated tubular structures
(small arrowheads), which are irregularly interrupted by intensely EMA-positive bands (large arrowheads). The
root sheath is EMA-negative (arrows). (D) Transverse section of a spinal nerve root. EMA-immunoreactivity
appears on ring-like structures of variable calibres. The sheath on the surface of the nerve root is EMA-negative
(arrows). (E) Higher magnification reveals the staining pattern of the ring-like structures within the spinal nerve
root. Strong EMA-immunoreactivity can be detected on the outer surface of the of the rings (arrows), whereas
weaker immunoreactivity appears on the inner surface (arrowheads). (F) and (G) Fig. G represents a higher
magnification of the boxed area in Fig. F. In a dorsal root ganglion, EMA-immunoreactivity is also detectable on
tubular profiles (small arrows), some of which seem to arise near the neuronal cell bodies (large arrows). The
meninges (small asterisks) between the dorsal root ganglion and the spinal cord (large asterisk), as well as the
sheath around the ganglion (large arrowheads) are all EMA-negative, as are satellite cells (small arrowheads) in
the ganglion. Thionin counterstain in A-G.
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In support of the myelin-type pattern of staining, longitudinal sections (Fig. 13C) revealed an
intense EMA-immunoreactivity on the outer surface of tubular structures, which were
orientated in parallel with the longitudinal axis of the nerve roots (small arrowheads in Fig.
13C). These tubular structures were interrupted by bands of intense EMA-immunoreactivity
(large arrowheads in Fig. 13C), which were interspersed along the tubes at distances of
approximately 5 to 150 microns.
In dorsal root ganglia EMA-immunostaining was also visible on tubular elements (small
arrows in Fig. 13F and G), some of which seemed to arise near the neuronal cell bodies (large
arrows in Fig. 13 G). The staining pattern of those tubular profiles was similar to that already
observed in the spinal nerve roots. Neuronal cell bodies, satellite cells (arrowheads in Fig.
13G), the meninges (small asterisks in Fig. 13F) between the dorsal root ganglion and the
spinal cord (large asterisk in Fig.13F) and the outer sheaths of the root ganglia (arrowheads in
Fig. 13F) were all EMA-negative.
4.2.2.2 P0-immunoreactivity
Immunostaining with antibodies directed against the major peripheral myelin glycoprotein
(P0) was performed to better characterise the EMA-positive structures. P0-immunoreactivity
was not detectable on any structures in the unlesioned spinal cord parenchyma (not shown).
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Figure 14 (A-D)
P0-immunoreactivity in unlesioned spinal nerve roots (A and B) and a dorsal root ganglion (C and 
D). (A) Un-lesioned spinal nerve roots captured as transverse (black asterisk) and longitudinal 
section (white asterisk). In the transverse section numerous ring-like P0-positive myelin sheaths 
can be seen. In the longitudinal section P0-positive myelin sheaths appear as longitudinally 
orientated tubes, which are interspersed by areas of P0-negativity (arrows). (B) Higher 
magnification of a transverse section reveals P0-immunoreactivity on the entire thickness of the 
"myelin-rings" (arrows). (C) and (D) Fig. D represents a higher magnification of the boxed area in 
Fig. C. Intensely P0-positive tubular profiles (arrows) can also be seen in a dorsal root ganglion 
lying on the surface of the spinal cord (asterisk). These tubes of peripheral myelin seem to arise in 
the near vicinity of neural cell bodies (arrowheads). Thionin counterstain in A-D.
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However, the typical distribution of peripheral myelin could be observed in unlesioned local
spinal nerve roots. In transverse sections (black asterisk in Fig. 14A and Fig. 14B), P0-
positive ring-like myelin sheaths with diameters ranging from approximately 2 to 15 microns
appeared to be densely packed throughout the nerve roots. The P0-immunoreactivity was
visible through the entire thickness of the myelin sheaths (e.g. arrows in Fig. 14B). Myelin of
large diameter axons was approximately 1.5 microns thick, whereas smaller axons had
correspondingly thinner myelin.
In longitudinal sections of the nerve roots (e.g. white asterisk in Fig. 14A), the labelled
peripheral myelin also displayed an orientated, tubular appearance. These tubes were
interspersed by areas of P0-negativity (e.g. arrows in Fig. 14A).
In dorsal root ganglia, P0-immunoreactivity revealed an overall distribution that was very
similar to that of EMA (compare Fig. 14C, D with Fig. 13F, G).
4.2.2.3 Double immunofluorescence
Double immunofluorescence of transverse sections of unlesioned spinal nerve roots was
performed to better characterise the relationship between the EMA-positive structures and P0-
positive peripheral myelin and NF200-positive axons.
A close spatial relationship was detected between the EMA-positive profiles and P0-positive
myelin sheaths (Fig. 15A and D). Standard epifluorescence microscopy revealed that the
outer surface of each P0-positive myelin sheath (green in Fig. 15A, C and D) seemed to be
closely associated with a thin EMA-positive ring (red in Fig. 15A, B and D). Epifluorescence
revealed EMA-staining only on the outer aspect of the ring-like structures (arrows in Fig.
15B), unlike peroxidase, which also revealed a weak pattern of staining on the inner aspect.
The spatial pattern of the EMA- and P0-positive profiles gave the impression that anti-EMA
and anti-P0 antibodies were not co-localised on the outer surface of the myelin sheath. It
seemed more likely that a structure different from peripheral myelin was stained by the anti-
EMA antibodies. This assumption was supported by the fact that, at the edge of the nerve
root, some myelin rings seemed to be out of shape (which was probably caused by the tissue
preparation), while the EMA-positive profiles retained their ring-like appearance (arrows in
Fig. 15D).
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Figure 15A-F (page 54)
Double immunofluorescence to reveal the spatial correlation between EMA-positive profiles and P0-positive
peripheral myelin and NF200-positive axons in transverse sections of unlesioned spinal nerve roots. EMA-
immunoreactivity is always demonstrated by Cy3-fluorescence (red), P0- and NF200-immunoreactive profiles
are demonstrated by Cy2-fluorescence (green). (A) EMA-immunoreactivity (red) can be seen around strongly
P0-positive myelin sheaths (green). (B) - (D) Higher magnification reveals the close spatial correlation between
the two antigens. (B) EMA single immunofluorescence demonstrates that the anti-EMA antibodies are
concentrated on the outer surface of ring-like structures in the nerve root (arrows). (C) P0-single
immunofluorescence shows the ring-like morphology of the myelin sheaths in transverse sections (arrows). (D)
Double immunofluorescence clearly demonstrates that the EMA-positive profiles tightly cover the P0-positive
myelin sheaths. At the edge of the nerve root some myelin rings appear to be out of shape, while the EMA-
positive profiles retain their ring-like appearance (arrows). (E) EMA-positive ring-like profiles (red) also
surround NF200-positive axons (green) in the nerve roots. (F) High magnification reveals that specific EMA-
immunoreactivity (arrows) cannot be seen directly on the axonal surface. The distance between the axons and
the EMA-positive ”rings” seems to correspond with the thickness of the P0-myelin sheaths seen in Fig. C and D.
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Double immunofluorescence with anti-EMA and anti-NF200 antibodies demonstrated the
spatial relationship between the EMA-positive structures and the NF200-positive axons in the
nerve roots. Each NF200-positive nerve fibre (green in Fig. 15E) seemed to be surrounded by
a thin EMA-positive ring (red in Fig. 15E). However, high magnification demonstrated a
distance of approximately 1 to 2 microns between the EMA-positive rings (red in Fig. 15F)
and the NF200-positive axons (green in Fig. 15F). This distance clearly corresponded with
the thickness of the P0-positive myelin sheaths seen in Fig. 15C and D.
In summary, EMA-immunoreactivity seemed to be associated with structures that tightly
covered the outer (and possibly also the inner) surface of P0-positive myelin sheaths of
NF200-positive axons in the spinal nerve roots. Perineurial structures, however, appeared to
be EMA-negative.
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4.2.3. EMA-immunoreactivity in the spinal cord and spinal nerve roots after
experimental compression injury
Four and 7 days p.o.: By 4 days p.o. (the earliest survival time studied), compression of the
spinal cord resulted in an injury site, which extended over several segments. At this survival
time, EMA-positive structures could not be observed in the lesion (Fig. 16A) or in the
adjacent intact spinal cord parenchyma (not shown). A thionin counterstain demonstrated that
many cells with small, segmented or rounded nuclei, typical for neutrophils and phagocytic
microglia/macrophages, had entered the lesion site (arrows in Fig. 16A).
By seven days p.o., the lesion site still consisted of cellular and axonal debris which had
already been partly cleared up by the phagocytic macrophages/microglia (arrows in Fig. 16B).
NF200-immunoreactivity revealed the absence of spared NF200-positive nerve fibres within
the lesion site (not shown).
At this survival time, EMA-positive structures were still not detectable in the lesion site
(black asterisk in Fig.16B). EMA-immunoreactivity in the local, damaged spinal nerve roots
(white asterisk in Fig. 16B) demonstrated a loss of the relatively uniform architecture seen in
the intact nerve roots (e.g. compare Fig. 16B with Fig. 13D). Among only occasional strongly
EMA-positive ring-like structures (arrowheads in Fig. 16B), a less intense and more diffuse
EMA-immunoreactivity could be observed in the damaged spinal nerve roots.
Fourteen days p.o.: By 14 days p.o., the lesion site had become infiltrated by EMA-positive
profiles (arrows and arrowheads in Fig. 16C). Within the spinal cord the stained elements
appeared to be restricted to the lesion site. EMA-immunoreactivity was not only detectable
near the surface of the lesioned spinal cord (arrows in Fig. 16C), but also in a relatively
limited area deep within the centre of the lesion (arrowheads in Fig. 16C). Surprisingly,
EMA-positive profiles were not detectable between these superficial and deeper areas. Higher
magnification (e.g. Fig. 16D and E) revealed EMA-immunoreactivity on longitudinally
orientated bundles of overlapping and interweaving profiles (arrows in Fig. 16D). These
bundles were scattered among EMA-negative, thionin-stained macrophages (arrowheads in
Fig.16D). Some of the EMA-positive structures appeared to be of a bipolar spindle-shaped
morphology (not shown), whereas most of them seemed to be tubular (e.g. arrows in Fig.
16E).
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Figure 16A-F (page 57)
Pathological consequences of the spinal cord compression. EMA-immunoreactivity in the injured spinal cord
and spinal nerve roots at 4 and 7 days p.o. (A and B), and EMA- and P0-positive profiles in the lesioned spinal
cord at 14 days p.o. (C-F). (A) EMA-immunoreactive profiles cannot be detected in the lesioned spinal cord by
4 days p.o. A thionin counterstain reveals that, at this survival time, the necrotic tissue has already become
massively infiltrated by phagocytic macrophages/microglia possessing typical small thionin-stained nuclei
(arrows). (B) By 7 days p.o., numerous large phagocytic macrophages/microglia (arrows) can be seen in the
lesion site (black asterisk), where EMA-positive structures are still not detectable. EMA-immunoreactivity in a
damaged spinal nerve root (white asterisk) which lies on the surface of the spinal cord, reveals the loss of the
relative uniform architecture of the EMA-positive profiles within the nerve root. Among only occasional
strongly EMA-positive ring-like structures (arrowheads), a less intense and more diffuse EMA-
immunoreactivity can be detected. (C) Overview of a lesioned spinal cord at 14 days p.o. EMA-
immunoreactivity is detectable in local spinal nerve roots (asterisks) but now also in the lesion site. EMA-
positive profiles seem to be restricted to the regions near the surface (arrows) and to a relatively limited area
deep within the centre (arrowheads) of the lesioned spinal cord. (D) and (E) Figure E represents a higher
magnification of the boxed area in Figure D. Near the surface of the lesioned spinal cord longitudinally
orientated bundles of EMA-positive tubular profiles (arrows) can be seen scattered amongst numerous thionin
stained macrophages (arrowheads in D). Strongly EMA-positive bands can be seen on these tubular profiles
interspersed at variable distances (arrowheads in E). (F) Near adjacent slide to that seen in Figure C. P0-
immunohistochemistry reveals a comparable staining pattern for P0 as seen for EMA. Longitudinally orientated
P0-positive myelin sheaths can be detected near the surface (arrows) and in the centre (arrowheads) of the
lesioned spinal cord. Thionin counterstain in A-F.
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P0-immunohistochemistry was performed to determine if the close relationship between
EMA-positive structures and peripheral myelin identified in normal spinal nerve roots also
existed in the lesioned spinal cord. The first P0-positive profiles to be detected in the lesion,
also appeared at 14 days p.o. Longitudinally orientated P0-positive myelin sheaths appeared
near the surface of the cord but also in deeper areas of the lesion site. P0-immunoreactivity in
a slide nearly adjacent to that shown in Figure 16C (see Fig. 16F) closely resembled the
staining pattern and orientation of the EMA-positive profiles within the lesion site. This
similarity in the distribution of the stained elements for both antibodies was consistent at later
survival times (not shown).
At this survival time, many NF200-positive axons could also be detected within the lesion site
(not shown). The distribution and orientation of regenerating nerve fibres was very similar to
that already described in the first part of this thesis (see above).
Twenty-one to 28 days p.o.: By 21 and 28 days p.o., the lesion site had become progressively
infiltrated by increasing numbers of EMA-positive profiles. At these survival times, EMA-
immunoreactivity was detectable on a loose network of longitudinally orientated individual
spindle-shaped or tubular profiles (arrows in Fig. 17A) and also on bundles of these profiles
(arrowheads in Fig. 17A) within the entire territory of the lesion. Some of the EMA-positive
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Figure 17 (A-D)
Massive infiltration of the lesion site by EMA-positive profiles at 21 and 28 days p.o. (A) An increased 
number of EMA-positive profiles can be detected within the lesion site at 21 days p.o. EMA-
immunoreactivity seems to be associated with  individual tubular profiles (arrows) as well as with bundles of 
these profiles (arrowheads), which form a loose, longitudinally orientated network throughout the lesion site. 
(B) Some of the stained profiles reach a considerable length of several hundred microns (arrows). The 
strongly EMA-positive bands (arrowheads), which appear at irregular intervals, give the impression that 
these profiles are segmented. (C) The entire lesion site appears to be infiltrated by a huge number of EMA-
positive profiles at 28 days p.o. EMA-immunoreactive processes within the lesion site have formed an 
overlapping and interwoven framework, which displays an overall longitudinal orientation. (D) EMA-
immunoreactivity at the dorsal root entry zone probably reveals the source of the EMA-positive cells in the 
lesion site. In the spinal nerve root (white asterisk) strongly EMA-positive tubular profiles are again 
detectable. Numerous EMA-positive profiles (arrows) can be seen entering the lesioned spinal cord (black 
asterisk) from this spinal nerve root. EMA-positive profiles near the dorsal root entry zone have already 
adopted a longitudinal orientation (arrowheads). Thionin counterstain in A-D. 
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Figure 18 A-F (page 60)
High magnification reveals that EMA-immunoreactivity is associated with cellular profiles in the lesion site (A-
D). P0-positive myelin sheaths display a distribution similar to that of the EMA-positive cells (E-F). (A) EMA-
immunoreactivity is clearly associated with a bipolar, spindle-shaped cell (arrows), which possesses an ovoid
nucleus (arrowhead). (B) Most intense EMA-immunoreactivity appears on the outer surface of the stained cells
(arrowheads). EMA-negative, thionin-stained cells of a similar morphology (arrows) can be seen in the vicinity
of the EMA-positive cells. Both types of cells possess an eccentric and ovoid nucleus. (C) Some of the EMA-
positive cells seem to lose their spindle-shaped morphology and switch to a more tubular appearance. In these
cells the nucleus appears to be more in line with the main body of the cell processes (arrowheads). Many of the
EMA-positive cells give the appearance of being linked, end-to-end, forming long chains of cells, and in the
regions of contacts, strongly EMA-positive bands can be detected (small arrows). The wall of small vessels in
the lesion site are EMA-negative (large arrows). (D) Very short distances between the EMA-positive bands
(arrows) give the impression that the bands not only appear at the points of contact between two different
profiles, but also in the course of a single process. A thionin-stained nucleus is located in the centre of an EMA-
positive cell (arrowhead). (E) Longitudinally orientated P0-positive myelin sheaths (arrows) can be seen within
the lesion site, one of which is closely associated with a thionin-stained ovoid nucleus (arrowhead). (F) A P0-
positive myelin-sheath seems to be interrupted by a short P0-negative segment (arrow). Another P0-positive
myelin sheath can also be seen closely associated with an eccentrically located and thionin-stained ovoid nucleus
(arrowhead). Thionin counterstain in A-F
61
tubular profiles reached a considerable length up to several hundred microns (arrows in Fig.
17B). The overlapping and intermingling profiles formed a framework which was clearly
orientated in parallel with the longitudinal axis of the spinal cord (Fig. 17A-C).
Numerous, strongly EMA-positive profiles (arrows in Fig. 17D) could be seen traversing the
dorsal root entry zone between the spinal nerve roots (white asterisk in Fig. 17D) and the
lesioned spinal cord (black asterisk in Fig. 17D). In the vicinity of the dorsal root entry zone,
these profiles could be seen adopting a longitudinal orientation (arrowheads in Fig. 17D).
High magnification of the EMA-positive profiles within the lesion site revealed that EMA-
immunoreactivity was clearly associated with bipolar, spindle-shaped cells (arrows in Fig.
18A), possessing an eccentric and ovoid nucleus (arrowhead in Fig. 18A). The most intense
EMA-immunoreactivity was detectable on the outer surface of these cells (arrowheads in Fig.
18B). Among these EMA-positive cells, EMA-negative, thionin-stained cells of similar
morphology (arrows in Fig. 18B) could also be detected in the near vicinity. It seemed that
some of the EMA-positive cells lost their spindle-shaped morphology and switched to a more
flat and tubular appearance. In these cells the nucleus was no longer eccentrically located but
more in line with the main body of the cell processes (arrowheads in Fig. 18C and D).
Many of the stained cells gave the appearance of being linked, end-to-end, forming long
chains of cells (e.g. Fig. 18C). In these regions of contact, strong EMA-immunoreactivity
could be detected on small vertical bands (e.g. small arrows in Fig. 18C). On the cell profiles
of other EMA-positive cells, several of these bands were detectable at very short distances
A B
D
FE
C
Results
Figure 19 (A-F)
62
(Legend see page 63)
Results
Figure 19A-F (page 62)
Double immunofluorescence to reveal the spatial relationship between EMA-positive cells and P0-positive
peripheral myelin within the lesion site at 28 days p.o. EMA-immunoreactivity is demonstrated by Cy3-
fluorescence (red), P0-immunoreactive structures are demonstrated by Cy2-fluorescence (green). Fig. A/B and
E/F show the corresponding single immunofluorescence pictures of the double-immunofluorescence pictures of
Fig. C and D. (A) Deep within the centre of the lesion, a longitudinally orientated P0-positive myelin sheath
(arrows) can be seen to be P0-negative for a short segment (arrowhead). (B) Intense EMA-immunoreactivity can
be seen on a bipolar spindle shaped cell (arrows) possessing an ovoid nucleus (arrowhead). (C) Double
immunofluorescence clearly demonstrates the close spatial relationship between the two stained structures. The
P0-positive myelin sheath seems to be located within the EMA-positive cell profiles, since intense EMA-
immunoreactivity can be detected upon the surface of the P0-positive myelin sheath (arrowheads). (D) - (E) In
the regions of the strongly EMA-positive bands (arrows in Fig. D and F), P0-immunoreactivity is not detectable
(small arrows in Fig. D and E). EMA-immunoreactivity upon the surface of the P0-positive myelin sheaths can
also be observed on these cells.(arrowheads in D).
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(e.g. arrows in Fig. 18D). This led to the assumption that strong EMA-positive bands not only
appeared on points of contact between two different cells but also in the course of a single
process.
P0-immunohistochemistry again revealed a similar staining pattern as seen for EMA-
immunohistochemistry. P0-positive myelin (e.g. arrows in Fig. 18E) could be seen associated
with longitudinally orientated bipolar spindle shaped cells which possessed an eccentric ovoid
nucleus (e.g. arrowheads in Fig. 18E and F). Furthermore, short P0-negative segments could
be detected at irregular distances on the P0-positive myelin tubes (e.g. arrow in Fig. 18F).
As already seen for normal spinal nerve roots, a close relationship between the EMA-positive
cells and P0-positive peripheral myelin could be observed in sections processed for EMA/P0-
double immunofluorescence (Fig. 19A-F). The longitudinally orientated P0-positive myelin
sheaths appeared to be located within the profiles of the bipolar, EMA-positive cells. A lack
of P0-immunoreactivity could regularly be observed where the strongly EMA-positive bands
appeared on the spindle shaped cells (e.g. arrows in Fig. 19D-F). Only rarely could EMA-
positive profiles be identified in the absence of P0-staining (not shown).
It is widely accepted that the onset of Schwann cell myelination is initiated by close axon-
Schwann cell contacts. Therefore, double immunofluorescence with anti-EMA and anti-
NF200 antibodies was performed in the lesioned spinal cord. Many regenerating NF200-
positive axons could still be detected within the lesion site at 28 days p.o. (e.g. green profiles
in Fig. 20A and C). EMA-positive cells (large arrows in Fig. 20B and C) and profiles (small
arrowheads in Fig. 20B and C) within the lesion site were always associated with NF200-
positive nerve fibres. In some areas, small calibre NF200-positive axonal profiles were
wrapped around the EMA-positive cells (small arrows in Fig. 20C), whereas, in other regions,
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Figure 20A-F (page 64)
Double immunofluorescence to reveal the spatial relationship between EMA-positive cells (red) and NF200-
positive axons (green) (A-C) and to differentiate between NGFr-positive, de-differentiated Schwann cells
(green) and EMA-positive cells (red) within the lesion site at 28 days p.o. (D-F). Fig. A/B and E/F demonstrate
the corresponding single immunofluorescence pictures of the double immunofluorescence picture of Fig. C and
D. (A) NF200 single immunofluorescence reveals numerous axons deep within the lesion site. A segment of a
large diameter axon seems to be only weakly NF200-positive (arrows) (B) An EMA-positive spindle-shaped cell
(arrows) and two EMA-positive processes (arrowheads) can be detected in the same region deep within the
lesion site. (C) Double immunofluorescence clearly reveals that the EMA-positive cell is closely associated with
the NF200-positive axon in the region of the weak NF200-immunoreactivity (large arrows). The EMA-positive
processes (small arrowheads) can be seen in close relationship to medium-sized, NF200-positive axons. Small
diameter NF200-positive axons are wrapped around the EMA-positive cell and the processes (small arrows). A
yellow fluorescence-signal, which normally appears in regions of close spatial correlation of two antigens, is
only rarely detectable (large arrowheads). (D-F) A NGFr-positive/EMA-negative spindle-shaped cell with an
ovoid nucleus (arrows in D and E) can be seen near an EMA-positive/NGFr-negative process (arrowheads in D
and F) deep within the centre of the lesion.
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large- and medium-sized nerve fibres seemed to be located inside the EMA-positive cellular
profiles (large arrowheads in Fig. 20C). However, many NF200-positive axons of every size
could be seen in the absence of EMA-positive cells.
Double immunofluorescence for EMA/NGFr revealed NGFr-positive cells (green profiles,
arrows in Fig. 20D) intermixed with EMA-positive cells (red profiles, arrowheads in Fig.
20D) within the lesion site. Only a few cells displayed both, NGFr- and EMA-
immunoreactivity but not in the meaning of a close local co-localisation of the antigens.
These cells appeared to be partly EMA- and partly NGFr-positive (not shown). Qualitatively,
the NGFr-positive cells out-numbered the EMA-positive cells at this survival time.
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5. DISCUSSION
5.1.    Part 1: Involvement of the cell adhesion molecules L1 and N-CAM in attempted
endogenous tissue repair after partial spinal cord transection
The present investigation has demonstrated the capacity of NGFr-positive non-neuronal cells
to migrate into the lesion site and to progressively form an overall longitudinally orientated
network of interwoven cell bundles and processes, which was clearly associated with
substantial and directional axonal re-growth. A similar pattern of in-growth by NGFr-positive
Schwann cells has previously been observed following experimental spinal cord compression
injuries (Guth et al., 1994; Brook et al., 1998) and in traumatically injured human spinal cords
(Wang et al., 1996). These observations indicate that the endogenous tissue repair processes
following SCI are more extensive and better organised than has been previously appreciated.
It has, furthermore, been reported that Schwann cells transplanted into the lesioned spinal
cord, spontaneously formed a longitudinally orientated framework (Weidner et al., 1999).
However, the mechanisms that influence the formation of the framework and its orientation,
as well as the directional axonal in-growth, are largely unknown. In an attempt to begin
defining the regulation and restriction of this behaviour, we have investigated the expression
and distribution of cell adhesion molecules in the lesion site.
Western blot analysis from both, normal as well as lesioned spinal cord tissue verified the
specific recognition of L1 and N-CAM antigens by the antibodies used in these experiments.
The polyclonal anti-L1 antibody identified a single band of specific staining with an apparent
molecular weight of approximately 190 kDa, which is compatible with the molecular weight
of the cell adhesion molecule L1 (Rathjen and Schachner, 1984). Similarly, the polyclonal N-
CAM antibody identified three prominent bands of relative molecular weights of
approximately 115, 138 and 177 kDa, which are compatible with the three mature isoforms of
N-CAM (Edelman, 1983).
In the present investigation, strong L1- and N-CAM-immunoreactivity could be detected on
the cellular framework within the lesion site. The two adhesion molecules L1 and N-CAM are
known to play an important role during morphogenesis of the neural system as well as in PNS
regeneration. They are expressed by Schwann cells and axons during neuronal development
and re-expressed by de-differentiated Schwann cells and axons after peripheral nerve injury
(Daniloff et al., 1986; Jessen et al., 1987; Rutishauser and Jessell, 1988; Martini, 1994). L1
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and N-CAM are involved in Schwann cell-Schwann cell adhesion, which is perhaps important
for the formation of the bands of Büngner after peripheral nerve injury (Daniloff et al., 1986;
Rutishauser et al., 1988; Seilheimer and Schachner, 1988). Neural cell adhesion molecule
expression by Schwann cells might therefore also be involved in the formation of the
orientated cellular framework within the lesion after SCI.
The adhesion molecules L1 and N-CAM also play important roles in initial axon-Schwann
cell and axon-axon contacts (Martini and Schachner, 1986; Martini, 1994) and are reported to
be involved in axonal growth-cone mobility by interfering with the motive apparatus
(Seilheimer and Schachner, 1988; Burden-Gulley et al., 1995). Therefore, L1 and N-CAM
seem to be fundamental for neuronal migration along bundles of pre-existing Schwann cells
and axons, for axon fasciculation and for the correct guidance of outgrowing axons during
neural development as well as during PNS regeneration (Pollerberg et al., 1987; Kamiguchi
and Lemmon, 1997). The appearance of L1- and N-CAM-immunoreactivity on the orientated
cellular framework of peripheral NGFr-positive Schwann cells within the lesion site in the
present investigation could, at least partly, explain why regenerating axons associating with
these cells, adopted a distinct directionality.
From transplantation studies, it is known that a PNS-like environment (presented by
peripheral nerve segments or Schwann cells grafted into CNS lesions) is able to support some
degree of CNS axonal regeneration (Richardson et al., 1980; David and Aguayo, 1981).
Neural cell adhesion molecules have been reported to be involved in the interactions between
regenerating CNS axons and Schwann cells in peripheral nerve grafts (Zhang et al., 1995;
Woolhead et al., 1998). In the present investigation, de-differentiated Schwann cells migrated
into the lesion site, where they formed a PNS-like environment, which strongly expressed L1
and N-CAM and supported substantial CNS axonal in-growth.
The lack of NF200-positive nerve fibres within the lesion at 3 days p.o., as well as the
progressive appearance of NF200-positive axons with increasing survival times, strongly
suggests that there was no axonal sparing and that all axons, which subsequently appeared in
the lesion, were due to regeneration. This interpretation is supported by further investigations
on the same spinal cord tissue, which revealed the presence of numerous regenerating
B50/GAP-43-positive intrinsic spinal cord neurons in the spinal grey matter close to the
lesion interface (Brook et al., 2000).
It seems reasonable to assume that most of the axonal in-growth into the pseudo-PNS
environment of the lesion was derived from a peripheral source such as the dorsal root
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ganglia. However, at the rostral and caudal borders of the lesion, numerous fine NF200-
positive axonal sprouts could be seen extending from the spinal cord parenchyma as
extensions of the severed ends of large calibre axons and penetrating the lesion for several
hundred microns. Further investigations (not part of the present thesis) have shown that only a
few calcitonin gene-related peptide-positive nerve fibres or substance P-positive nerve fibres
could be detected within the lesion (Brook et al., 2000). These peptidergic nerve fibres
represent a sub-population (>50%) of sensory dorsal root ganglion neurons (Schoenen et al.,
1989). Another population of sensory dorsal root ganglion neurons, the sensory A-fibres, have
already been reported to ”stop dead” at the border of such spinal cord lesions without growing
into or beyond it (Neuman and Woolf, 1999). Therefore, it would seem that relatively few of
the regenerating axons observed at these short survival times within the lesion site are derived
from a peripheral source.
It has previously been shown that GABAergic and glycinergic spinal cord interneurons are
capable of growing into the lesion site following compression injury of the rat spinal cord
(Brook et al., 1998). Furthermore, regenerative re-growth of a range of CNS-derived neuronal
populations into Schwann cell-seeded guidance channels, transplanted as bridges across
complete spinal cord transections, have been reported by Mary Bunge and colleagues. In their
experiments, propriospinal, sensory, motor, serotoninergic and catecholaminergic fibres were
detected crossing the lesion interface and entering the graft (Guest et al., 1997; Xu et al.,
1997; Xu et al., 1999). However, the lack of anterograde-labelled nerve fibres in the lesion
site of the same animals used in the present study, revealed the absence of re-growth of
descending corticospinal axons into the lesion (Brook et al., 2000), confirming previous
reports made by other groups (Schnell and Schwab, 1990; Joosten et al., 1995; Houweling et
al., 1998). It is interesting that corticospinal axon growth is reportedly guided by both L1- and
N-CAM-mediated interactions during development (Joosten, 1994; Cohen et al., 1997). It is
therefore likely that this population of axons failed to enter the lesion site despite the
extensive expression of L1 and N-CAM because of the presence of inhibitory molecules in
the environment of the lesioned axons. Myelin-associated proteins, tenascin-C, sulphated
proteoglycans and semaphorins are all known to influence which populations of fibres are
able to penetrate a lesion (Schwab and Bartholdi, 1996; Stichel and Müller, 1998; Pasterkamp
et al., 1999).
We found relatively few cells and nerve fibres being PSA-N-CAM-positive within the lesion
site. The polysialylated form of N-CAM has been reported to play an important role in axonal
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growth, guidance and fasciculation during both, development and regeneration of the nervous
system (Edelman, 1983; Joosten and Bär, 1999). It is also known that PSA-N-CAM is an
important molecule for the appropriate development of the corticospinal tract (Joosten, 1994;
Daston et al., 1996). The poor re-expression of PSA-N-CAM after spinal cord hemisection in
the present investigation might be an additional factor contributing to the lack of corticospinal
axonal re-growth into the lesion site.
Another interesting observation of the present investigation was the apparent shift of
orientation of the cellular framework and of the accompanying axons within the lesion site.
The orientation shifted from longitudinal to more ventro-dorsal between 28 and 56 days p.o.
This directional change, however, was not associated with a reduced expression of the cell
adhesion molecules L1 and N-CAM. Qualitative observations suggested that, at 56 days p.o.,
an even greater number of L1- and N-CAM-positive profiles within the lesion site displayed
the same intensity of staining as seen at 28 days p.o. It is possible that, at the later survival
times, other factors which influenced the orientation of both, the non-neuronal cells and the
axons, were released into the lesion site or into the Spongostan matrix (a collagen matrix
which was inserted during the surgical procedure to induce rapid hemostasis) dorsal to the
lesion. The laminectomy above the lesion site, for example, resulted in the exposure of the
Spongostan matrix to muscle fibres. It is likely that factors derived from these fibres might
have been involved in the shift of the orientation of the cellular and axonal framework within
the lesion site. Of course, it is also possible that local and as yet undetermined factors were
involved in the longitudinal alignment during the first few weeks after the trauma and that
these factors disappeared at the later survival times.
One of the goals of the present investigation was to clearly identify the cells participating in
the formation of the orientated cellular framework. NGFr-immunohistochemistry revealed the
non-neuronal cell invasion of the lesion as early as 3 days p.o. At this survival time, most of
those cells appeared in the immediate vicinity of the dorsal root entry zone and near the dorsal
surface of the lesion site. In the more ventral regions only occasional NGFr-positive cells
could be seen. This behaviour and the bipolar, spindle-shaped morphology of the stained
cells, suggested that many of these cells were de-differentiated Schwann cells derived from
damaged spinal nerve roots. However, leptomeningeal cells from the pial surface, which are
also NGFr-positive, have also been shown to contribute to such lesions (Frisen et al., 1992;
Risling et al., 1992; Pasterkamp et al., 1999).
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Although it has previously been reported that trk-A-immunohistochemistry is useful to
identify leptomeningeal cells in CNS lesions (Frisen et al., 1998), this was not possible in the
present investigation, since substantial trk-A-immunoreactivity was also detectable in
macrophages within the lesion (data not shown). Due to the absence of a specific
leptomeningeal cell marker, double immunofluorescence with a range of antibodies was
performed to differentiate between Schwann cells and leptomeningeal cells in the lesion site.
De-differentiated Schwann cells in damaged spinal nerve roots were found to be NGFr-,
S100-, L1- and N-CAM-positive, as already reported by others (Kahn et al., 1983; Johnson et
al., 1988). Leptomeningeal cells in the pia mater, however, were NGFr-positive, but, at the
same time, remained S100-negative, confirming previous observations (e.g. Frisen et al.,
1992; Frisen et al., 1998; Pasterkamp et al., 1999). These different staining patterns allowed
us to distinguish between the two cell types within the lesion. Cells displaying NGFr- and
S100-immunoreactivity were interpreted as being Schwann cells, whereas NGFr-
positive/S100-negative cells were interpreted as being leptomeningeal cells. Although a
quantitative analysis of the double-stained sections was not practicable, S100-negative
leptomeningeal cells were clearly out-numbered by the S100-positive Schwann cells within
the lesion. The NGFr-positive leptomeningeal cells, furthermore, demonstrated intense N-
CAM-staining. L1/NGFr double immunofluorescence, however, revealed that leptomeningeal
cells were L1-negative.
At the longer survival times, relatively few NGFr-/L1-positive cells could be detected within
the lesion. Most of the L1-immunoreactivity was detectable on slender profiles of relatively
uniform calibre, which were associated with NGFr-positive/L1-negative cells. From this
staining pattern, it could reasonably be interpreted that, at these relatively late survival times,
most of the cells in the lesion were leptomeningeal cells (NGFr-positive/L1-negative)
associated with L1-positive axons. However, this seems unlikely because the majority of
NGFr-positive cells were still S100-positive. A more likely explanation for this observation
would be that bundles of axons became ensheathed by Schwann cells, as previously reported
by Matthews and colleagues (Matthews et al., 1979), and that L1-immunoreactivity had
subsequently become re-distributed to the points of contact between axons and Schwann cells.
Such a spatial re-distribution of L1 on Schwann cells associated with axons has already been
described by others (Martini et al., 1994; Zhang et al., 1995).
The role of leptomeningeal cells in the endogenous tissue repair processes remains
controversial. Axon growth-promoting properties of these cells have been reported for
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lesioned motor and sensory axons (Risling et al., 1992; Frisen et al., 1993). Leptomeningeal
cells reportedly express the growth-promoting ECM molecules fibronectin and laminin
(Matthiessen et al., 1991; DeGiorgio et al., 1997). The expression of the cell adhesion
molecule N-CAM might, furthermore, also contribute to the growth-promoting properties of
leptomeningeal cells. On the other hand, leptomeningeal cells have been reported to produce
growth-inhibitory molecules such as tenascin-C, CSPG and semaphorin-III (Hirsch and Bahr,
1999; Pasterkamp et al., 1999). Additionally, in vivo and in vitro experiments have shown the
role of leptomeningeal cells in the inhibition of axonal outgrowth (Ajemian et al., 1994;
Hirsch and Bahr, 1999).
Apart from these direct influences on axonal growth, leptomeningeal cells are also known to
inhibit axonal growth through indirect mechanisms. Leptomeningeal cell-astrocyte
interactions have been shown to result in the formation of the astrocytic glia limitans by the
induction of end-feet and the synthesis of basal lamina molecules at the lesion interface
(Abnet et al., 1991; Sievers et al., 1994). Furthermore, tissue culture studies have shown that
leptomeningeal cells reduce the axon growth-promoting properties of astrocytes. This effect
has been reported to be brought about by reducing the production of the growth-promoting
molecule laminin and increasing the production of the growth-inhibitory molecules tenascin-
C and CSPG (Ness and David, 1997).
In the present investigation, GFAP-positive reactive astrocytes extended bundles of
longitudinally orientated, long slender processes for distances of up to several hundred
microns into the lesion. An intimate intermingling of these astrocytic processes with
leptomeningeal cells and Schwann cells at the interface and also deeper within the lesion
could be observed, giving the impression that ”flares” of astrocytic processes had penetrated
the lesion. Despite the close relationship between reactive astrocytes and leptomeningeal cells
at the lesion interface, there was no evidence of a dense overlap or coalescence of the
astrocytic processes, an occurrence that would be a characteristic behaviour of the glia
limitans. In contrast, the comparison of adjacent and near adjacent sections, processed for
NF200-immunohistochemistry, strongly suggested that the astrocytic flares were acting as
bridges, along which regenerating axons were carried from the spinal cord parenchyma into
the Schwann cell/leptomeningeal cell-containing framework of the lesion site. Similar
observations have been made at the lesion interface following penetrating injuries of human
spinal cords (Bunge et al., 1997) and also following transplantation of Schwann cell-coated
guidance channels into experimental spinal cord lesions (Guest et al., 1997). These
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observations indicate that, in the presence of Schwann cells, astrocyte-leptomeningeal cell
interactions at the lesion interface do not necessarily result in an impenetrable barrier to the
passage of regenerating axons. The cellular intermingling within the flares showed strikingly
morphological similarities to the astrocyte-Schwann cell interactions that form during the
development and maturation of CNS-PNS interfaces at dorsal root entry zones and ventral
root exit points (for review see Golding et al., 1997). Furthermore, microtransplantation of
columns of Schwann cells into the rat thalamus have more recently been reported to result in
an intimate intermingling and co-operation between host astrocytes and donor Schwann cells.
In those experiments, host astrocytes became fully incorporated into the donor Schwann cell
columns, forming tightly packed bundles which contained numerous NF200-positive axons
and which were surrounded by a single basal lamina sheath (Brook et al., 2001).
5.2. Conclusions
In the past 20 years, considerable progress has been made in understanding the cellular and
molecular mechanisms which contribute to the lack of successful regeneration of lesioned
CNS axons (for reviews see: Schwab and Bartholdi, 1996; Fawcett and Asher, 1999). Based
on these findings, a range of promising intervention strategies have been developed and tested
under experimental conditions as well as in clinical trials (for recent reviews see: Jones et al.,
2001; Kwon and Tetzlaff, 2001; McKerracher, 2001). To date, however, relatively little is
known about the endogenous tissue repair processes which spontaneously occur during the
first weeks after SCI, and which seem to be much more organised and extensive than had
previously been appreciated.
The first part of the present investigation demonstrates several novel aspects of this attempted
endogenous tissue repair process.
It is remarkable that the formation of an orientated Schwann cell framework within the lesion
site, which had previously only been observed in the lesion site after spinal cord compression
injury, was also detectable after dorsal hemisection of the spinal cord. It can therefore be
concluded that the formation of an orientated Schwann cell framework within the lesion site
is a phenomenon which does not depend on the type of injury.
The attempt to identify which adhesion molecules may be involved in the re-organisational
processes during attempted tissue repair demonstrated the intense and widespread expression
of L1 and N-CAM, but the relative lack of PSA-N-CAM on the cellular framework of the
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lesion site. To obtain a more detailed understanding of the functional roles of L1 and N-CAM
in the re-organisational processes, studies with L1 and N-CAM knock out mice are planned
for the future.
Although leptomeningeal cells have been identified to contribute to the non-neuronal cell
invasion, it seems that these cells are a minor cellular component of the lesion site. Their
exact role during the attempted tissue repair processes remains unclear. It seems that these
cells are involved in the apparent Schwann cell-astrocyte co-operation in the cellular bridges
or ”flares”, where axons cross from the intact spinal cord parenchyma to the lesion. Further
research into the properties of these cellular interactions at the lesion interface, may lead to a
means for improving the integration between peripheral and central glia and may thereby
improve the therapeutic usefulness of Schwann cells in transplantation strategies.
Although axonal regeneration was not abortive over the first 56 days p.o., an apparent shift of
direction of the regenerating axons and of the cellular framework was detectable at these later
survival times. This behaviour suggests that factors, probably derived from muscles fibres
above the lesion, may influence the orientation of both axons and the glial cells within the
lesion site. A better understanding of the mechanisms which influence this important change
in the cellular re-organisation will probably also help to develop future therapeutic strategies,
designed to maintain or even enhance the spontaneous and orientated regenerative events
after SCI.
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5.3.    Part 2: EMA-immunoreactivity in normal and lesioned spinal cords and spinal
nerve roots
EMA-immunohistochemistry was performed in an attempt to identify perineurial cells in the
lesion site after compression injury of the rat spinal cord. Similar to Schwann cells,
perineurial cells are components of peripheral nerves and known to be important for their
regeneration after injury (Shanthaveerappa and Bourne, 1966; Jurecka et al., 1975; Ohara et
al., 1986). This behaviour led to the notion that perineurial cells or perineurial-like cells of the
spinal nerve roots could also participate in the re-organisational events taking place after
spinal cord injury.
EMA, recognised by antibodies raised against a group of human milk fat globule membranes,
is a large glycoprotein expressed by a range of normal and neoplastic epithelial tissues
(Sloane and Ormerod, 1981; Perentes et al., 1987). EMA-immunohistochemistry plays an
important role in the diagnosis and differential diagnosis of cancers of epithelial organs
(Sloane and Ormerod, 1981; Pinkus and Kurtin, 1985; Perentes et al., 1987). However, EMA
is not only restricted to epithelia and epithelial-derived neoplasms, but can also be detected on
a range of tissues of mesenchymal origin (for review see e.g. Perentes and Rubinstein, 1987).
There may be a shared epitope between these two different tissues, although it is still
uncertain if the antigen recognised on non-epithelial tissues is identical to the EMA found in
epithelial tissues. Immunohistochemistry, using a monoclonal antibody against EMA, is a
popular method of identifying perineurial cells in normal peripheral nerves and peripheral
nerve tumours (Ariza et al., 1988; Theaker and Fletcher, 1989). The monoclonal antibody
used in the present investigation (Clone E29, Dako Diagnostics) has been reported to
consistently stain perineurial cells in both human as well as rat peripheral nerves and in
human peripheral nerve tumours (Ariza et al., 1988; Theaker and Fletcher, 1989; Weis et al.,
1994). The sheaths of spinal nerve roots have been reported to possess a unique histological
organisation which is not exactly identical to a normal perineurium, but contains perineurial-
like cells which blend from the perineurium into the root sheath (Benke and Röhlich, 1963;
Haller and Low, 1970).
Despite the perineurial-like cell components of the root sheaths, EMA-immunoreactivity was
not detectable on these structures in the present investigation. To the best of my knowledge,
there is no report of EMA-expression on the sheaths of dorsal nerve roots. Theaker and
colleagues detected EMA-immunoreactivity on both perineurial cells and arachnoid cells in
human tissue (Theaker et al., 1986; Theaker et al., 1988). However, in the present
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investigation, the sheaths which covered the dorsal root ganglia and which are reported to be
identical to a normal perineurium (Benke and Röhlich, 1963), were EMA-negative, as were
the meninges. It is of course possible that, in the rat, EMA is not expressed on the perineurial-
like cells of the inner layer of the root sheaths but this cannot explain the lack of EMA-
immunoreactivity on the perineurium of the root ganglia, where EMA-immunoreactivity has
previously been detected (Schröder et al., 1993; Weis et al., 1994). There is no report of
EMA-positive arachnoid cells of the meninges in rats. It is therefore possible that, in contrast
to human arachnoid cells, rat arachnoid cells do not express the epitope that is recognised by
the anti-EMA antibody. Another interpretation is that the failure to detect EMA-
immunoreactivity on these structures, might have been due to technical issues. This is
unlikely, however, since EMA-immunoreactivity was not absent in the nerve roots but was
detectable on tubular structures which had no similarities to a typical perineurium or
perineurial cells.
EMA-immunoreactivity on these tubular structures in normal nerve roots is another surprising
observation of the current investigation. Neither in human nor in rat spinal nerve roots or
peripheral nerves has a similar staining pattern previously been observed. It seemed that
EMA-immunoreactivity was somehow associated with myelinating Schwann cells in the
nerve roots, and this interpretation was supported by several morphological characteristics of
the stained elements.
In longitudinal sections of the nerve roots, EMA-immunoreactivity appeared on the outer
surface of the longitudinally orientated tubular profiles, which, in turn, were interrupted by
bands of intense EMA-immunoreactivity. These bands were interspersed along the tubes at
irregular distances. Some of them appeared at longer intervals of 50-150 microns, whereas
shorter distances could also be detected between other bands. The bands morphologically
resembled the nodes of Ranvier. However, due to the relatively short distances between some
of those bands, Schmidt-Lanterman incisures must also be considered to be stained. Although
normal microscopy did not provide sufficient resolution to clearly differentiate between these
two structures, it seems reasonable to assume that strong EMA-immunoreactivity appeared on
both, the nodes of Ranvier as well as on Schmidt-Lanterman incisures of myelinating
Schwann cells in the nerve roots.
The interpretation that the epitope recognised by the EMA antibody was associated with
myelinated structures, was supported by the fact that P0-positive peripheral myelin also
displayed a longitudinally orientated, tubular appearance in longitudinal sections of the nerve
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roots. Furthermore, the absence of P0-immunoreactivity detectable at variable distances on
the myelin sheaths, would be compatible with the absence of peripheral myelin at the nodes
of Ranvier or the Schmidt-Lanterman incisures.
In dorsal root ganglia, a similar staining pattern could be observed on the EMA-positive
tubular profiles and the P0-positive myelin sheaths, which both arose near the neuronal cell
bodies, and thereby might reflect the ensheathment of dorsal root ganglion axons by
myelinating Schwann cells.
The outer diameter of the EMA-positive ring-like structures, which were detectable in
transverse sections of spinal nerve roots ranged from approximately 3 to 15 microns, which is
compatible with the size of medium- and large-sized myelinated nerve fibres. EMA/NF200-
double immunofluorescence supported this interpretation, as each medium- and large-sized
NF200-positive nerve fibre seemed to be surrounded by a thin EMA-positive ring. The
distance of approximately 1 to 2 microns between the NF200-positive axons and the EMA-
positive rings was clearly compatible with the distance between the strong EMA-
immunoreactivity on the outer surface and the weaker and more irregular staining on the inner
surface of the EMA-positive ring-like structures in peroxidase stained sections. This distance,
furthermore, was compatible with the thickness of the P0-positive myelin sheaths in
transverse sections of spinal nerve roots.
EMA/P0-double immunofluorescence clearly confirmed the close relationship between the
EMA-positive rings and the P0-positive myelin. However, double immunofluorescence only
revealed strong EMA-immunoreactivity on the outer aspect of each myelin sheath, whereas
on the inner aspect EMA-immunoreactivity was not detectable. This, of course, might be due
to a lesser sensitivity of standard epifluorescence as compared to peroxidase-
immunohistochemistry, which already revealed a weak EMA-immunoreactivity on the inner
aspect of the rings.
All these results imply that the epitope recognised by the anti-EMA antibody was somehow
associated with myelinating Schwann cells or peripheral myelin. The latter of these
possibilities seems unlikely, due to the spatial relationship of the EMA- and P0-positive
profiles which was revealed by double immunofluorescence. It seemed that EMA- and P0-
immunoreactivity was not co-localised on the outer surface of the myelin sheath, but that the
EMA antibodies recognised a structure different from peripheral myelin. This interpretation
was supported by the observation that (probably due to the tissue preparation) some myelin
sheaths at the edge of a nerve root appeared to be out of shape, while the EMA-positive
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profiles retained their ring-like structure. Therefore, it seems more reasonable to conclude that
the epitope, which was recognised by the EMA antibody, was located on the outer or
abaxonal cell membrane of myelinating Schwann cells themselves. Another possible location
of the epitope could be the basement membrane which surrounds the Schwann cell on the
outer surface. This, however, would not explain the weak EMA peroxidase-staining on the
adaxonal surface.
It can be concluded that the EMA antibody used in this study recognised a structure
associated with myelinating Schwann cells. This fact is particularly surprising, since Schwann
cells in both humans and rats have constantly been reported to be EMA-negative (Perentes et
al., 1987; Perentes and Rubinstein, 1987; Theaker et al., 1988; Weis et al., 1994). What is
more, EMA-immunohistochemistry is a popular diagnostic method of differentiating between
neoplasms of perineurial and Schwann cell origin in humans (Perentes et al., 1987; Perentes
and Rubinstein, 1987; Theaker et al., 1988). There is only a single report of EMA-
immunoreactivity in Schwann cell-like tumour cells in malignant nerve sheath tumours in
humans (Hirose et al., 1992). These observations indicate that, under certain conditions,
”schwannoid” cells might be EMA-immunoreactive. However, Schwann cells of dorsal nerve
roots at the CNS-PNS interface, or Schwann cells in dorsal root ganglia are not reported to
possess a different histological organisation than Schwann cells in normal peripheral nerves,
which probably could explain the EMA-immunoreactivity in the nerve roots and root ganglia.
Hitchcock and Morris observed a significant cross-reactivity of the monoclonal E29-EMA
antibody to an epitope on reactive and neoplastic astrocytes (Hitchcock and Morris, 1987),
although these cell types had previously been reported to be EMA-negative when stained with
a polyclonal anti-EMA antibody (Sloane et al., 1983).
One reason for the unusual EMA-staining pattern in the present investigation might lie in the
way the tissue was processed prior to the immunohistochemical procedure. EMA-
immunoreactivity on perineurial cells has, so far, only been observed in rat tissue that was
fixed with glutaraldehyde (Schröder et al., 1993; Weis et al., 1994). In such tissue, Schwann
cells appeared to be EMA-negative. In the present investigation, however, the tissue was
fixed in paraformaldehyde. It is of course possible that different methods of tissue preparation
might result in different staining patterns and that in the present investigation, due to
paraformaldehyde fixation, an as yet hidden epitope was exposed on the Schwann cell surface
which was then recognised by the EMA antibody.
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Due to the failure to detect perineurial cells in the sheaths of the nerve roots and the dorsal
root ganglia by E29 EMA-immunohistochemistry, it was not expected to identify these cells
in the lesioned spinal cord by this technique. Nevertheless, we performed EMA-
immunohistochemistry and double immunofluorescence in lesioned spinal cord tissue at
various survival times, and thereby revealed further aspects which supported the notion that
EMA-immunoreactivity was associated with myelinating Schwann cells.
The first changes of EMA-expression after spinal cord compression were detectable in the
local spinal nerve roots which had also been injured during the surgical procedure. The more
diffuse and less intense EMA-staining pattern, which was accompanied by a loss of the
relatively uniform architecture of the EMA-positive profiles in the damaged spinal nerve
roots by 4 days p.o., is an interesting observation of the present investigation. After peripheral
nerve injury, Schwann cells transform, as is well known, from a myelinating or non-
myelinating phenotype to a de-differentiated and activated form (for review see Dezawa and
Adachi-Usami, 2000). A possible explanation for the decrease and change of EMA-
immunoreactivity in the damaged nerve roots, therefore, would be that myelinating Schwann
cells lose their EMA-immunoreactivity when becoming de-differentiated.
In the lesion site, EMA-immunoreactivity was detectable on profiles that ran parallel to the
longitudinal axis of the spinal cord, as early as 14 days p.o. High magnification clearly
revealed EMA-immunoreactivity on the outer surface of two different types of cells. The cells
which displayed a bipolar, spindle-shaped morphology strikingly resembled de-differentiated,
migrating Schwann cells, whereas the EMA-positive, more tubular cells were
morphologically similar to myelinating Schwann cells. The formation of longitudinally
orientated chains of the EMA-positive cells within the lesion is another observation which
indicates that the stained cells were Schwann cells, which are known to form longitudinally
orientated columns of similar morphology (bands of Büngner) during peripheral nerve
regeneration (Griffin and Hoffmann, 1993; Gilmore and Sims, 1995).
It has been reported that, between two and seven days after spinal cord compression, de-
differentiated, NGFr-positive Schwann cells invade the lesion site and become subsequently
associated with regenerating NF200-positive axons (Brook et al., 1998). It is furthermore
known that a close axon-Schwann cell relationship initiates the onset of myelination in de-
differentiated Schwann cells (Weinberg and Spencer, 1976; Wood et al., 1990), which thereby
lose their NGFr-immunoreactivity (Taniuchi et al., 1988). It is highly likely that, in the
present investigation, de-differentiated, EMA-negative Schwann cells began to enter the
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lesion site from the spinal nerve roots between three and seven days p.o. and, during the
following days, became associated with the first regenerating axons. Between 7 and 14 days
p.o., the Schwann cells that were in contact with those axons, re-adopted a myelinating
phenotype and thus became EMA-positive. This interpretation is supported by several
observations of the present investigation.
The fact that, at 14 days p.o., EMA-immunoreactivity was not only restricted to the
superficial regions but also to the relatively limited area deep within the centre of the lesion
indicates that EMA-positive cells entered the lesion site prior to becoming EMA-positive.
Furthermore, the longitudinally orientated framework of EMA-positive cell bodies and
processes, which was detectable throughout the lesion site at the later survival times (21 and
28 days p.o.), was strikingly similar to the NGFr-positive framework of the lesion site
observed by Brook and colleagues at 7 and 14 days p.o. (Brook et al., 1998). It is likely, that
the phenotypic alterations of the Schwann cells which, by the onset of myelination, lose their
NGFr-immunoreactivity and may become EMA-positive, are the explanation for the reduced
amount of NGFr-positive Schwann cells in the lesion at 21 and 28 days p.o. in the study of
Brook and colleagues but also for the increasing number of EMA-positive cells at these
survival times in the present investigation. NGFr/EMA-double immunofluorescence supports
this interpretation. Bundles of intermixed NGFr-positive/EMA-negative cells (de-
differentiated Schwann cells and leptomeningeal cells) and EMA-positive/NGFr-negative
cells (myelinating Schwann cells) could be seen within the lesion. The observation that some
cells were partly EMA- and partly NGFr-positive, strongly indicates that Schwann cells lose
their NGFr-immunoreactivity and become EMA-positive with more advanced survival times.
It is known that the shift from a de-differentiated to a myelinating phenotype is associated
with the formation of a new basal lamina around the Schwann cells (Griffin and Hoffmann,
1993; Gilmore and Sims, 1995). The basal lamina might, therefore, be a possible location of
the epitope recognised by the anti-EMA antibody. However, a fact which supports the
assumption that the epitope was not located on this structure is that the wall of small blood
vessels, which are also known to be surrounded by a basal lamina, appeared to be EMA-
negative both, in the unlesioned as well as in the lesioned spinal cord.
Another important observation of the present investigation was that, at 28 days p.o., strongly
EMA-positive cells could again be detected in the local spinal nerve roots. These cells,
however, were not only restricted to the nerve roots, but also penetrated the dorsal root entry
zone of the lesioned spinal cord. This behaviour strongly underlines the assumption that, on
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the one hand, Schwann cells in the nerve roots re-adopt their EMA-positive phenotype by the
onset of myelination and, on the other hand, the EMA-positive cells within the lesion site
originate from cells of the dorsal nerve root.
The appearance of increasing numbers of NF200-positive axons in the lesion site at later
survival times seems to be related to the re-growth of new axons rather than to sparing of
original axons, since NF200-positive axons were not detectable within the lesion site at earlier
survival times (3 days p.o.). A close relationship between axons and Schwann cells, a
prerequisite for the onset of Schwann cell myelination, was revealed by EMA/NF200 double
immunofluorescence. All EMA-positive cells within the lesion appeared to be in intimate
contact with large- and medium-sized NF200-positive axons. Surprisingly, yellow
fluorescence-signals, which normally appear in regions of strong spatial correlation of two
antigens in double immunofluorescence, were rarely detectable. The reason for this might lie
in the less intense NF200-immunoreactivity which could be seen in the corresponding single
immunofluorescence pictures. This lesser intensity might, in turn, be due to an insufficient
penetration of the anti-NF200 or the secondary Cy2-conjugated antibodies in regions where
the axons were associated with EMA-positive cells. The insufficient antibody penetration
might, of course, be due to technical problems, but could also support the hypothesis that the
EMA-positive cells ensheathe the axons and thereby prevent a sufficient exposure of the
axonal surface to the anti-NF200 antibodies. In contrast to the larger calibre axons, which
seem to be ensheathed by EMA-positive cells, small calibre NF200-positive axons appeared
to be only wrapped around the EMA-positive profiles.
Furthermore, the detection of longitudinally orientated P0-positive myelin sheaths, which
displayed a distribution strikingly similar to that of the EMA-positive cells, proves that
Schwann cell myelination occurs in the lesion site after compression injury. P0/EMA-double
immunofluorescence revealed, furthermore, the close relationship between the EMA-positive
cells and the P0-positive peripheral myelin within the lesion site. It became obvious that the
longitudinally orientated P0-positive myelin sheaths were located within the profiles of the
EMA-positive cells. An absence of P0-immunoreactivity could regularly be observed in the
regions where the strongly EMA-positive bands appeared on the cell processes, and thereby
supported the assumption that these regions reflect the nodes of Ranvier or Schmidt-
Lanterman incisures.
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5.4. Conclusions
In the second part of this investigation, EMA-immunohistochemistry was performed in an
attempt to identify perineurial or perineurial-like cells in the lesion site after compression
injury of the rat spinal cord. However, due to the unexpected EMA-staining pattern both, in
the unlesioned spinal nerve roots as well as in the lesioned spinal nerve roots and spinal
cords, we were not able to resolve the issue by this technique.
Although the monoclonal anti-EMA antibody used in this study has been reported to stain
perineurial cells of rat peripheral nerves (Schröder et al., 1993; Weis et al., 1994), neither
perineurial cells of dorsal root ganglia nor perineurial-like cells of spinal root sheaths were
found to be EMA-positive. On the contrary, the antibody seemed to recognise an epitope on
myelinating Schwann cells, which appeared in the lesion site by 14 days p.o., or on structures
that were closely associated with these cells, such as the basal lamina.
The most likely explanation for the unusual staining pattern may be that the method of tissue
fixation somehow influenced the exposure of the epitope both, on perineurial cells as well as
on Schwann cells. The exact reason for the strange staining pattern, however, remains unclear
and requires further biochemical investigations.
Normal microscopy of peroxidase immunohistochemistry and double immunofluorescence,
furthermore, does not provide sufficient resolution for the exact determination of the structure
on which the epitope (detected by the EMA antibody) was located. Additional investigations,
including other techniques such as electron microscopy, will therefore be needed for the
resolution of this issue.
However, in assumption that myelinating Schwann cells were stained using this antibody, it
was possible to show that after spinal cord compression injury these cells appear in the lesion
site as early as 14 days p.o. and get in close contact with regenerating axons.
If the results of the present investigation are reproducible in the future, EMA-
immunohistochemistry will be a helpful technique to detect myelinating Schwann cells in
paraformaldehyde-fixed material and to differentiate between these cells and de-differentiated
Schwann cells in the lesioned rat spinal cord.
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Abbreviations
AP Aminopyridine
BDNF Brain-derived nerve growth factor
BSA Bovine serum albumine
cAMP Cyclic-adenosine-monophosphate
CNS Central nervous system
CSPG Chondroitin sulphate proteoglycan
DAPI 4’,6-diamino-2-phenylindole
ECM Extracellular matrix
EGTA Ethylene glycol tetraacetic acid
EMA Epithelial membrane antigen
Fig. Figure/Figures
GABA Gamma amino butyric acid
GFAP Glial fibrillary acidic protein
GAP Growth-associated protein
IL-1 Interleukin-1
i.p. Intraperitoneal
MAG Myelin-associated glycoprotein
MBP Myelin basic protein
N-CAM Neural cell adhesion molecule
NF Neurofilament
NGF Nerve growth factor
NGFr Low-affinity nerve growth factor receptor
NGr Nogo receptor
P0 Major peripheral myelin glycoprotein
PBS Phosphate-buffered saline
PFA Paraformaldehyde
PNS Peripheral nervous system
p.o. Post operation
PSA Polysialylated
RPM Rounds per minute
SCI Spinal cord injury
SDS Sodium dodecyl sulphate
TBS Tris-buffered saline
TTBS Tween tris-buffered saline
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